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The Endoplasmic Spreading Mechanism of Fibroblasts: Showcasing the Integrated 
Cytoskeleton 
 
Christopher D. Lynch 
 
 
Cell motility is an essential process that depends on a coherent, cross-linked cytoskeleton 
that physically coordinates the actions of numerous structural and signaling  molecules. In 
culture, a common feature of cells is the coherent movement of the endoplasm reticulum 
and membranous organelles toward the periphery during substrate adhesion and 
spreading. The actin cross-linking protein, filamin (Fln), has been implicated in the 
support of   three-dimensional cortical actin networks capable of both maintaining cellular 
integrity and  withstanding large forces. Although numerous studies have examined cells 
lacking one of the  multiple Fln isoforms, compensatory mechanisms can mask novel 
phenotypes only observable by further Fln depletion. Indeed, shRNA-mediated 
knockdown of FlnA in FlnB–/– mouse embryonic fibroblasts (MEFs) causes a novel 
endoplasmic spreading deficiency as detected by endoplasmic reticulum markers. 
Microtubule (MT) extension rates are also decreased but not by peripheral actin flow, 
because this is also decreased in the Fln-depleted system. Additionally, Fln-depleted 
MEFs exhibit decreased adhesion stability that leads to increased ruffling of the cell edge, 
reduced adhesion size, transient traction forces, and decreased stress fibers. FlnA–/– 
MEFs, but not FlnB–/– MEFs, also show a moderate defect in endoplasm spreading, 
characterized by initial extension followed by abrupt retractions and stress fiber fracture. 
FlnA localizes to actin linkages surrounding the endoplasm, adhesions, and stress fibers. 
Thus I suggest that Flns have a major role in the maintenance of actin-based mechanical 
linkages that enable endoplasmic spreading and MT extension as well as sustained 
traction forces and mature focal adhesions.  I also report that treatment with the calpain 
  
inhibitor N-[N-(N-Acetyl-L-leucyl)-L-leucyl]- L-norleucine (ALLN) restores 
endoplasmic spreading and focal adhesion (FA) maturation in the absence of Fln.  Further, 
expression of calpain-uncleavable talin, but not full-length talin, also rescues 
endoplasmic spreading in Fln-depleted cells and indicates a crucial role for stable, mature 
FAs in endoplasmic spreading. Because FA maturation involves the vimentin 
intermediate filament (vIF) network, I also examined the role of vIFs in endoplasmic 
spreading.  Wild-type cells expressing a dominant-negative vimentin variant incapable of 
vIF polymerization exhibit deficient endoplasmic spreading as well as defects in FA 
maturation.  ALLN treatment restores FA maturation despite the lack of vIFs, but does 
not restore endoplasmic spreading.  Consistent with a role for vIFs in endoplasmic 
spreading, adhesive structures do not contain vIFs when the endoplasm does not spread. 
Fln-depleted cells also exhibit a microtubule-dependent mistargeting of vIFs.  Thus, I 
propose a model in which cellular force generation and interaction of vIFs with mature 
FAs are required for endoplasmic spreading.  Additionally, I discuss future lines of 
investigation concerning the role of FlnA in the endoplasmic spreading mechanism as 
well as mechanosensitive functions of FlnA.  Finally, I speculate on a potential 
application of endoplasmic spreading deficiencies as hallmarks of metastatic breast 
cancer. 
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Chapter	  1	  -­‐	  Introduction	  	  
 
1.1	  –	  Cell	  motility	  
  
Cell motility is a critical aspect of life, and potentially death, for higher organisms.  
Cells must be motile during development to ensure proper orientation and function of the 
embryo (Locascio & Nieto, 2001) (Yang & Weinberg, 2008).  Cells must also be motile 
for wounds to heal (Abercrombie & Heaysman, 1954).  Unregulated motility, however, 
has the potential to develop into metastatic cancer (Friedl & Gilmour, 2009).  
Consequences of motility aside, the mechanisms involved in cell motility are complex, 
involving hundreds of molecules and coordinated signaling events (Zaidel-Bar, Itzkovitz, 
Ma'ayan, Iyengar, & Geiger, 2007).  Additionally, not all cell types move in similar ways 
(Hatten, 1999), thereby complicating efforts to simplify cell motility into a series of 
universal steps.  Model cell systems and predictable assays are useful in this respect.  In 
this thesis, I utilize mouse embryonic fibroblasts (MEFs) and cell spreading assays in an 
effort to mechanistically understand the movement of the endoplasm (defined later in 
section 1.13).  The remainder of this chapter introduces necessary background 
information.  Chapters 2 and 3 each cover experimental results at the start, and end with 
discussion of the meaning of these results in a broader context.  Chapter 4 looks ahead to 
future work concerning the endoplasm and related molecular players. I conclude by 
suggesting a possible role for my studies in diagnosing cancer. 
 




Cell motility is a vast and fascinating subject.  Different cell types move in 
different ways to different cues, complicating efforts to define motile components 
universal to all cells.  One system in which motility is frequently studied is the fibroblast 
(Dokukina & Gracheva, 2010) (Giannone & Sheetz, 2006) (Figure 1). 
 
 
Figure 1 – Schematic of a migrating fibroblast and cytoskeletal structures related to motility (Vicente-




Fibroblasts are derived from the mesoderm and make up the connective tissue that 
provides support in our bodies (Tarin & Croft, 1969).  One of the main functions of 
fibroblasts is to secrete the extracellular matrix (ECM) (Leiss, Beckmann, Giros, Costell, 
& Fassler, 2008).  The ECM is a complex, three-dimensional web of secreted proteins 
and glycosaminoglycans that gives structural support to the cells embedded within it.  
Furthermore, ECM proteins elicit outside-in signaling events in cells, thereby modulating 
cellular behavior (Leiss, Beckmann, Giros, Costell, & Fassler, 2008).  Different ECM 
proteins, such as fibronectin and collagen, trigger distinct events in cells, particularly 
related to their motility (Kostic, Lynch, & Sheetz, 2009). 
Fibroblast motility is a well-studied phenomenon, with certain aspects seen in 
other cell types (Kostic & Sheetz, 2006) (Kostic, Sap, & Sheetz, 2007).  That said, 
studying the motile processes of this cell type is an enormous and somewhat daunting 
task since cells do not exhibit all of their motile processes in any convenient time period 
for in vivo observation.  Indeed, cell motility is often thought of as a modular process 
(Dobereiner, 2005), with certain modules used only in response to very specific, and 
sometimes rare, stimuli.  Modules used only in healing a wound, for example, would 
never be seen while observing an unwounded organism.  Likewise, modules used only in 
the early stages of development or activated during neoplastic growth would also be 
difficult to observe.  Before discussing these modules further, an overview of the relevant 
cellular structures is required. 
 




In the same way that the skeletal system provides structure and support for our 
bodies, the cytoskeleton provides structure and support for cells.  However, unlike our 
skeletal system, the cytoskeleton is a highly dynamic structure that responds to 
intracellular and extracellular cues.  Three of the main functions of the cytoskeleton are 
intracellular trafficking, cellular stability, and cell motility.  As such, the fibroblast 
cytoskeleton has three subsystems that roughly correlate with these functions: 
microtubules, intermediate filaments, and microfilaments (though, to be clear, due to the 
high level of interdependence between these systems, discussed in section 1.12, it is 
difficult to assign a unique function to any one cytoskeletal element). 
Microtubules (MTs) are highly dynamic, hollow, tube-like polymers of α- and β-
tubulin heterodimers that serve a number of important roles in the cell, including acting 
as a platform for intracellular transport, forming the mitotic spindle, providing structural 
support, and functioning in motility (Nogales, 2000).  MTs are seeded by α-β tubulin 
heterodimers (Weisenberg, Borisy, & Taylor, 1968) that arrange end-to-end to form 
linear protofilaments.  13 protofilaments arrange around a central axis, resulting in a 
tubular structure (Desai & Mitchison, 1997).  The MT (+) end refers to the β-tubulin-
capped end while the (-) end refers to the α-tubulin-capped end.  Both α- and β-tubulin 
bind GTP, but only the GTP on β-tubulin is hydrolysable (Weisenberg, Deery, & 
Dickinson, 1976).  The term “dynamic instability” describes the assembly and 
disassembly mechanisms of MTs (Mitchison & Kirschner, 1984).  GTP-loaded tubulin 
adds to the growing (+) end, but shortly after incorporation into the MT, GTP is 
hydrolyzed to GDP.  The kinetics of GDP-tubulin favor depolymerization, but GDP-
tubulin cannot be removed from a MT unless it is at the (+) end.  Therefore, unless GTP-
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tubulin has subsequently added onto the (+) end, a cycle of depolymerization will be 
initiated, usually referred to as a catastrophe (Figure 2).  
 
Figure 2 – Schematic of microtubule dynamics (Akhmanova & Steinmetz, 2008). 
Intermediate filaments (IFs) are less dynamic structures than MTs, that are 
classically thought to provide the cell with structural support and resilience against 
outside forces (Helfand, Chang, & Goldman, 2003).  There are two distinct IF networks 
in cells, one nuclear, and one cytoplasmic (Herrmann & Aebi, 2004).  The nuclear IF 
network makes up the nuclear lamina that supports the inner nuclear membrane 
(Gruenbaum, Margalit, Goldman, Shumaker, & Wilson, 2005).  The cytoplasmic IF 
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network connects the nuclear membrane with peripheral adhesive structures that function 
to create a stable link between cells and their surroundings.  Similar to MTs, cytoplasmic 
IFs play a role in motility as well.  In humans, IF proteins are encoded by over 65 genes 
and grouped into five types based on sequence homology (types 1-5) (Fuchs & Weber, 
1994) (Herrmann, Bar, Kreplak, Strelkov, & Aebi, 2007).  They are also diverse between 
cell types, including keratins and desmins in epithelial and muscle cells, respectively 
(Herrmann, Bar, Kreplak, Strelkov, & Aebi, 2007).  However, for the purposes of this 
thesis and fibroblasts in particular, further discussion of IF proteins will focus on another 
IF protein, vimentin.   
Microfilaments, comprised mainly of actin, are highly dynamic polymers that 
provide structural support as well as drive cell motility via actin polymerization against 
the cell membrane (Insall & Machesky, 2009). Actin polymerization is an extremely 
complicated process involving several actin-binding partners that function in nucleation 
of filamentous actin (F-actin) from globular actin (G-actin), sequestration of G-actin, 
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filament elongation, capping, and severing, as well as branching and bundling (Figure 3). 
 
Figure 3 – Mechanisms and proteins involved in actin-driven membrane protrusion (Pollard & Borisy, 2003) 
 In brief, actin polymerization proceeds through the three phases known as lag, 
elongation, and steady-state.  In the lag phase, G-actin monomers assemble into unstable, 
short oligomers.  After reaching a threshold length, the elongation phase begins at both 
ends of the filament.  Finally, in the steady-state phase, G-actin continues to add onto F-
actin, but the total mass of F-actin does not change.  G-actin concentration plays a central 
role in this process.  For each end of a filament, a critical concentration exists below 
which elongation does not take place.  The end with the lower critical concentration is 
referred to as the (+) end while the other is the (-) end.  At a certain G-actin concentration 
intermediate between the critical concentrations of the (+) and (-) ends, G-actin is added 
onto the (+) end at the same rate as it dissociates from the (-) end.  The result is a 
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“treadmilling” filament that displaces, but never changes in length.  This process is the 
basis of actin polymerization exerting an outward force on the cell membrane (Pollard & 
Borisy, 2003) (Pollard, 1986).  Actin microfilaments can also serve as a platform through 
which other proteins exert force. 
 
1.4	  –	  Force	  generation	  
 
Another critical aspect of cell motility is force generation on the external 
environment.  The field of cell motility is rife with examples of cells using forces to 
explore and probe their environment (Ananthakrishnan & Ehrlicher, 2007).  For example, 
as alluded to above, actin polymerization exerts an outward force on a cell membrane 
under tension to drive cell protrusion (Le Clainche & Carlier, 2008), the cell membrane 
resists actin polymerization forces with tensile forces directed inward (Gauthier, Fardin, 
Roca-Cusachs, & Sheetz, 2011), traction forces are exerted on the substrate during cell 
migration (Oliver, Dembo, & Jacobson, 1995) (Harris, Wild, & Stopak, 1980), and forces 
associated with rigidity sensing allow the cell to respond to the rigidity of its 
surroundings (Kostic & Sheetz, 2006) (Kostic, Lynch, & Sheetz, 2009) (Kostic, Sap, & 
Sheetz, 2007).  In fibroblasts, the majority of forces are exerted through myosins (Cai, et 
al., 2010).  Myosins comprise a large family of ATP-dependent motor proteins that 
associate with actin (Sweeney & Houdusse, 2010).  In fibroblasts, myosin II is the 
predominant isoform involved in force generation on the ECM (Vicente-Manzanares, Ma, 
Adelstein, & Horwitz, 2009).  Three pairs of polypeptides make up non-muscle myosin 
II: two heavy, two regulatory light and two essential light chains. In mammals, three 
heavy chain genes myh9, myh10 and myh14 form myosin IIa, IIb and IIc, respectively.  
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Upon ATP hydrolysis, the head domains of myosin heavy chain produce what is referred 
to as a power stroke, in which myosin II pulls on its associated actin microfilaments and 
generates contractile forces.  To migrate, a cell must be able to exert contractile forces on 
a stable substrate, and for this, a cell must form connections with the substrate. 
 
1.5	  –	  Focal	  adhesions	  
 
The fluid lipid bilayer known as the cell membrane determines the cellular 
volume, defining the cell interior and exterior.  The cell membrane also integrates a 
number of polysaccharides and proteins that allow communication between interior and 
exterior cellular regions.  For the purposes of this thesis, cells connect to a substrate 
through focal adhesions (other connections exist, such as tight junctions and 
hemidesmosomes in epithelial layers, but they will not be a focus of this work).  Focal 
adhesions are large, dynamic multimolecular plaques that mature from smaller, punctate, 
focal contacts (Geiger & Bershadsky, 2001).  In the context of fibroblast cell motility, 
focal adhesions connect to the aforementioned ECM proteins coating the substrate, 
sometimes eliciting different cellular responses depending on the type of ECM protein 
(Kostic, Lynch, & Sheetz, 2009).  Within focal adhesions, integrins are the primary 
molecular connections between the cell and ECM proteins (Miranti & Brugge, 2002).  
Integrins are heterodimeric transmembrane proteins that interact with ECM proteins at 
the cell exterior and cytoskeletal mediator proteins, like talin and filamin (Fln), inside the 
cell (Kiema, et al., 2006).  These mediator proteins connect focal adhesions to the actin 
cytoskeleton, allowing forces generated within the cytoskeleton to be transmitted through 
focal adhesions, to the substrate (Fournier, Sauser, Ambrosi, Meister, & Verkhovsky, 
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2010).  Overall, more than a hundred proteins are associated with focal adhesions at some 
point in the lifetime of an adhesion (Figure 4) (Zaidel-Bar, Itzkovitz, Ma'ayan, Iyengar, & 
Geiger, 2007). 
 
Figure 4 – Focal adhesion proteins are numerous and promiscuous in their binding (Zaidel-Bar, Itzkovitz, 
Ma'ayan, Iyengar, & Geiger, 2007) 
 Having covered the general terminology and basic components behind cell 
motility and fibroblast behavior, the remainder of this section delves deeper into the focal 




1.6	  -­‐	  Fibroblast	  Spreading	  
 
As discussed previously, cell motility is a modular process (Dubin-Thaler, et al., 
2008).  Certain modules are common between cell types, making information gathered 
from model systems relevant to other, more specialized systems (rigidity sensing 
mechanisms discovered in fibroblasts were also found to be relevant in neurons) (Kostic 
& Sheetz, 2006) (Kostic, Sap, & Sheetz, 2007).  On the other hand, some modules can 
only be observed at specific time points in an organism’s life cycle, making a 
comprehensive study of cell motility onerous.  To address this difficulty, our lab and 
others developed fibroblast spreading assays with high spatial and temporal resolution in 
two dimensions (Dubin-Thaler, Giannone, Dobereiner, & Sheetz, 2004).  Fibroblast 
spreading assays involve dropping a suspension of fibroblasts onto cover slips coated 
with ECM proteins and allowing them to spread (see Figure 17A).  ECM proteins help 
replicate an in vivo-like environment, since fibroblasts naturally secrete these proteins.  In 
vivo, fibroblasts experience integrin-ECM interactions involving a number of ECM 
proteins, complicating efforts to isolate that aspect of the system.  Furthermore, in vivo 
motility assays suffer from low resolution that is not appropriate for answering certain 
questions, for example, how proteins stretch in the cell (discussed later in section 4.2).  
Three-dimensional (3-D) motility assays suffer from similar issues (Harunaga & Yamada, 
2011).  Two-dimensional (2-D) spreading assays, on the other hand, offer high spatial 
and temporal resolution and greater control over experimental conditions (Dobereiner, 
2005).  In addition, spreading assays give researchers greater control over the outside-in 
signaling experienced by the cell.  Of course, any 2-D assay designed to replicate an in 
vivo environment will fall short in some aspects, as cells are known to behave in 
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completely different ways in response to 2-D and 3-D environments (Cukierman, 2001).  
That said, cells only have a set number of motility modules, and while the manner in 
which the modules are utilized may differ from 2-D to 3-D, the 2-D system still 
showcases the modules in a cell’s motility arsenal.  
Early studies of fibroblast spreading assays led to yet another reason to use these 
assays to study motility.  Dobereiner and colleagues, among others, observed that 
fibroblast spreading is a predictable process that allows the observation of most motility 
modules in under an hour (Dobereiner, 2005).   Any differences that arise as a result of 
genetic manipulations or chemical treatments can therefore by readily assessed, no matter 
which motility module they relate to (Zhang, Jiang, Cai, Monkley, Critchley, & Sheetz, 
2008). 
 
1.7	  –	  Phases	  of	  fibroblast	  spreading	  
 
A wild-type fibroblast undergoes cell spreading in a predictable, highly 
reproducible manner.  When a fibroblast in suspension contacts an ECM-coated surface, 
the cell starts by “tiptoeing” on the surface, essentially touching down in some regions 
and lifting up in others (Ryzhkov, Prass, Gummich, Kuhn, Oettmeier, & Dobereiner, 
2010).  This is generally regarded as an exploratory phase preceding the basal phase, or 
phase 0 (P0), of spreading (Dobereiner, Dubin-Thaler, Giannone, Xenias, & Sheetz, 
2004).  During P0, the cell determines the chemical suitability of the substrate and shows 
little to no signs of an increase in spread area.  If appropriate molecules (such as ECM 
proteins) are present at the correct concentrations, the cell begins the P1 stage of 
spreading.  P1 is characterized by the cell achieving the majority of its fully spread area.  
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As this phase usually lasts between 5-10 minutes, it is sometimes referred to as the fast 
spreading phase.  Expansion of the spread area during P1 primarily involves actin 
polymerization at the leading edge of the cell exerting force on the cell membrane, 
causing the cell to expand outward (Dobereiner, Dubin-Thaler, Giannone, Xenias, & 
Sheetz, 2004).  Observing this process is similar to watching pancake batter spreading in 
a fry pan. Punctate focal contacts begin to form during this stage as well.  Because the 
cell membrane is, at least initially, of a constant area, expansion necessarily leads to the 
cell eventually reaching the maximum of its supply of membrane area.  This causes an 
increase in membrane tension (forces directed inward by the membrane) (Gauthier, 
Fardin, Roca-Cusachs, & Sheetz, 2011).  Put simply, as the cell spreads to a greater area, 
its membrane begins to become taut.  
The next phase of fibroblast spreading is P2, often referred to as the contractile 
phase.  During P2, the cell continues spreading, but intermittently, between cycles of 
myosin contraction (Giannone, et al., 2007).  These contractions serve a number of 
purposes.  For one, they allow cell membrane area to increase via exocytosis (membrane-
bound intracellular vesicles add to membrane area by fusing with the cell membrane and 
releasing their contents) (Gauthier, Rossier, Mathur, Hone, & Sheetz, 2009).  They also 
allow the cell to sense the physical properties of the surface.  Surface conformation 
(Mathur, Moore, & Sheetz, 2012) and rigidity have the capacity to affect cell motility 
(Kostic & Sheetz, 2006) (Kostic, Lynch, & Sheetz, 2009) (Kostic, Sap, & Sheetz, 2007), 
just as chemical composition of the surface does (Weiss, 1958) (Curtis & Wilkinson, 
1997).  Since the cell is no longer continuously spreading, this phase is sometimes 
referred to as slow spreading.   
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Importantly, significant traction forces are generated in P2 (Cai, et al., 2010), 
which of course require a physical link between the cell and the substrate.  To accomplish 
this, the aforementioned punctate focal contacts enlarge and mature into focal adhesions, 
yielding strong, stable connections to the surface that can withstand high levels of force 
generated intracellularly by myosin II.   
 
1.8	  –	  Adhesion	  maturation	  and	  disassembly	  
	  
Mature focal adhesions can experience binding of more than 100 different 
proteins during their lifetime (Zaidel-Bar, Itzkovitz, Ma'ayan, Iyengar, & Geiger, 2007).  
The evolution of a focal contact to a focal adhesion is a complex process involving a 
number of these proteins, but its essence can be broken down into a series of steps 
(Figure 5).   
 
 
Figure 5 – Schematic showing the stages of focal adhesion maturation and proteins associated with each stage 
(FX = focal contact, FA = focal adhesion, FB = fibrillar adhesion (Zaidel-Bar, Cohen, Addadi, & Geiger, 2004) 
 
First, during P1, hyaluronan-mediated contacts form between the cell and the ECM-
coated surface.  Hyaluronan is a glycosaminoglycan found in the plasma membrane of 
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cells.  Hyaluronan-mediated contacts are transient and last on the order of tens of seconds 
(Zaidel-Bar, Cohen, Addadi, & Geiger, 2004).   
Following establishment of a hyaluronan-mediated contact, additional proteins are 
recruited to the contact region, qualifying it a focal contact, by definition.  Focal contact-
associated proteins include integrin heterodimers αV-β3, integrin-cytoskeleton mediator 
proteins talin, vinculin, and α-actinin, the scaffolding protein paxillin, and the signaling 
protein focal adhesion kinase (FAK) (Zaidel-Bar, Cohen, Addadi, & Geiger, 2004).  In 
fact, both focal contacts and focal adhesions contain integrin-binding proteins, actin-
binding proteins, and scaffolding proteins that are arranged in a hierarchical manner. 
(Figure 6) (Kanchanawong, et al., 2010).   
 
 
Figure 6 – Hierarchical assembly of focal adhesions away from the ventral surface of the cell. (Kanchanawong, 




During P2, focal contacts become focal adhesions and disassemble.  Again, this 
transformation reflects recruitment of various proteins.  In this case, proteins such as the 
adaptor protein zyxin define the structure.   
Another aspect of focal adhesions is their disassembly.  Focal adhesion 
disassembly is accomplished through proteolysis of adhesion proteins.  Specifically, the 
calcium-dependent protease calpain cleaves talin and filamin, as well as other adhesion 
proteins like paxillin, vinculin, and zyxin.  Importantly, calpain-mediated talin proteolysis 
is a rate-limiting step in adhesion disassembly (Franco, et al., 2004).  Put simply, if talin 
is not cleaved by calpain, adhesions will not turnover and will instead grow and mature.  
In terms of size, focal adhesions are larger in area than focal contacts.  In fact, adhesion 
area tends to increase with applied contractile force (Riveline, et al., 2001).  Contractile 
forces applied to adhesions originate from actomyosin structures. 
1.9	  –	  Actomyosin	  structures	  
 
Actin microfilaments come together to form several types of structures.  In 
particular, microfilaments can aggregate to form stress fibers and 3-D networks of actin.  
Stress fibers are one of the primary means that forces are exerted on the surface through 
focal adhesions.  Actin networks give the cell shape and structure.  Both actin-based 
structures are highly dynamic and can contain contractile elements. 
 Cells generate three types of stress fiber: ventral stress fibers, dorsal stress fibers, 




Figure 7 – Stress fiber varieties and assembly mechanisms (Hotulainen & Lappalainen, 2006) 
Ventral stress fibers join distant focal adhesions on the ventral surface.  Through a 
combination of cell membrane tensile forces pushing inward on the polymerizing actin 
network at the cell edge and contractile forces within the network itself, a meshwork of 
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microfilaments becomes a thick stress fiber known as a transverse arc.  Transverse arcs 
flow rearward, toward the cell center, in a process known as retrograde flow.  Once close 
to the cell center, transverse arcs accumulate and surround the endoplasm, the organelle-
rich, central region of the cell (covered in section 1.13).   
 Dorsal stress fibers initiate at focal adhesions and extend from the ventral surface 
of the cell toward the dorsal surface.  Dorsal stress fibers connect at actin-rich nodes with 
the transverse arcs accumulated around the endoplasm.  In this way, forces generated by 
myosin anywhere within connected transverse arcs and dorsal stress fibers will be 
transmitted to the surface (Hotulainen & Lappalainen, 2006).   
 All of these structures originate from three-dimensional actin networks that 
require supporting proteins to “prop up” the network.  In fibroblasts, this role is filled by 
Flns. 
1.10	  –	  Filamins	  
 
Flns have been implicated in numerous aspects of cellular shape and motility.  
Flns are ~280 kDa, ~80 nm long protein monomers consisting of an N-terminal actin-
binding domain followed by 24 IgG-like domains that have the ability to homo- and 
heterodimerize (Hartwig & Stossel, 1975) and support the formation of three-dimensional 
actin networks (Hartwig & Shevlin, 1986) (Gorlin, et al., 1990) (Takafuta, Wu, Murphy, 
& Shapiro, 1998) (Flanagan, 2001)  as well as affect membrane-cytoskeleton interactions 





Figure 8 - Schematic showing domain structure of filamin (CH = calponin-homology) (Razinia, Makela, Ylanne, 
& Calderwood, 2012) 
 
FlnA and FlnB are the two major Fln isoforms expressed in fibroblasts (Stossel, et al., 
2001), representing ~90% of total Fln levels (Baldassarre, Razinia, Burande, Lamsoul, 
Lutz, & Calderwood, 2009).  Recent rheological studies on Fln/actin gels have 
determined that Flns enable a high degree of resilience in actin networks (Kasza, et al., 
2009) (Schmoller, Lieleg, & Bausch, 2009), giving the cell the ability to form relatively 
soft actin networks at low Fln concentrations and bundle stress fibers at high Fln 
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concentrations (Tseng, An, Esue, & Wirtz, 2004) (Esue, Tseng, & Wirtz, 2009).  Flns 
also bind to integrins (Sharma, Ezzell, & Arnaout, 1995) (Loo, Kanner, & Aruffo, 1998) .  
In fact, both Fln and the integrin-cytoskeleton mediator protein talin bind to overlapping 
sites on integrins, and integrin phosphorylation can serve to modulate both talin and Fln 
binding (Kiema, et al., 2006) (Takala, et al., 2008).  
While FlnA knockout mouse embryonic fibroblasts (MEFs) have shown minimal 
motility defects (Feng, et al., 2006), numerous studies on the FlnA-deficient M2 
melanoma cell line have found extensive blebbing and motility-related defects 
(Cunningham, Gorlin, & Kwiatkowski, 1992) (Flanagan, 2001), malformed actin 
architecture (Flanagan, 2001), and the inability to sense external rigidity (Byfield, et al., 
2009) and control cellular stiffness (Kasza, et al., 2009).  Additionally, Fln mutations can 
cause periventricular nodular heterotopia (PVNH) in humans, reflecting neuronal motility 
deficiencies (Fox, et al., 1998).  On the other hand, FlnB -/- MEFs have been reported to 
have motility defects and disrupted actin architecture (Zhou, et al., 2007).  Importantly, 
there is high homology between Fln isoforms (Stossel, et al., 2001), and they appear to 
compensate for each other (Baldassarre, Razinia, Burande, Lamsoul, Lutz, & Calderwood, 
2009).   
Clearly, Flns have a dramatic impact on the actin cytoskeleton.  Importantly, they 
also link the actin cytoskeleton to the IF cytoskeleton by interaction with the IF protein 
vimentin. 
 




Vimentin is to IFs as actin is to microfilaments.  Vimentin is one of many proteins 
that make up IFs, however in mesenchymal cells, vimentin is the primary IF precursor 
(Mendez, Kojima, & Goldman, 2010).  Structurally, vimentin is a type 3 IF protein 
composed of globular head and tail domains connected by an α-helical rod domain 
(Figure 9).   
 
 
Figure 9 - Ribbon structure of vimentin (Herrmann, Bar, Kreplak, Strelkov, & Aebi, 2007) 
 
Vimentin monomers interact in parallel along their rod domains to form coiled-coil 
dimers.  Dimers associate with one another in a staggered, anti-parallel fashion, giving 
rise to non-polar tetramers.  Vimentin tetramers associate laterally to form unit-length 
filaments, ~ 60 nm-long IFs.  Unit length filaments then anneal laterally, forming longer 
vimentin intermediate filaments (vIFs) (Figure 10) (Herrmann & Aebi, 2004).  
 
Figure 10 – Intermediate filament formation from tetramers, to unit length filaments, to mature intermediate 
filaments (Herrmann & Aebi, 2004) 
 Considering the important role of the IF cytoskeleton, it is surprising that 
vimentin knockout mice showed no signs of abnormal development (Colucci-Guyon, 
Portier, Dunia, Paulin, Pournin, & Babinet, 1994).  However, upon closer examination, 
  
22 
vimentin knockout mice exhibited numerous defects.  For example, vimentin knockouts 
are prone to renal failure due to a lack of vascular adaptation (Terzi, et al., 1997).  In fact, 
vimentin is crucial in directing the physical responses of the vasculature after changes in 
blood pressure (Schiffers, et al., 2000) (Davies, Spaan, & Krams, 2005).  Loss of 
vimentin also causes impaired motor coordination and delay of the regeneration of 
injured dorsal root ganglion neurons (Colucci-Guyon, Gimenez Y Ribotta, Maurice, 
Babinet, & Privat, 1999).  Additionally, expression and distribution of adhesion 
molecules in lymphocytes is altered upon vimentin loss (Nieminen, Henttinen, Merinen, 
Marttila-Ichihara, Eriksson, & Jalkanen, 2006).  Overall, though its absence is not lethal 
to an organism, vimentin is critical in diverse cellular processes. 
 Vimentin’s interaction with FlnA is a recent development.  Though the specific 
binding site of vimentin on FlnA has not yet been discovered, co-immunoprecipitation 
and dot-blot studies have shown that vimentin interacts with FlnA along FlnA domains 1-
8 (Kim & McCulloch, 2011) (Kim, Nakamura, Lee, Hong, Perez-Sala, & McCulloch, 
2010) (Kim, Nakamura, Lee, Shifrin, Arora, & McCulloch, 2010).  Thus, the FlnA-
vimentin interaction provides a direct link between the microfilament and IF cytoskeletal 
systems, though other proteins are known to mediate this type of linkage as well (Fuchs 
& Karakesisoglou, 2001).   
 
1.12	  –	  Interplay	  of	  cytoskeletal	  systems	  
 
Each cytoskeletal system interacts with the others through various mediator 
proteins.  Therefore, perturbations of one cytoskeletal system will likely have 
consequences for the others (Eckert, 1986).  Importantly, interaction of cytoskeletal 
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systems mediates the positioning of the nucleus and other organelles (Jefferson, Leung, & 
Liem, 2004) and provides the cell with higher stiffness than any cytoskeletal system 
alone (Esue, Carson, Tseng, & Wirtz, 2006).  Additionally, all three cytoskeletal systems 
interact with focal adhesions.  The actin cytoskeleton affects focal adhesions primarily 
through the application of force (Ananthakrishnan & Ehrlicher, 2007) (Fournier, Sauser, 
Ambrosi, Meister, & Verkhovsky, 2010).  As discussed previously, forces applied via 
actomyosin structures stimulate adhesion growth.  Notably, IFs and MTs can influence 
focal adhesions as well.  Specifically, IFs have been shown to induce focal adhesion 
maturation and growth (Tsuruta, 2003) while MTs stimulate degradation of adhesions 
(Krylyshkina, et al., 2002) (Krylyshkina, et al., 2003).   
 
1.13	  –	  Thesis	  rationale	  
 
In order to better understand the functions of Fln in cell motility, I initially 
focused on the well-characterized process of cell spreading and polarization (Giannone, 
et al., 2007) where a standard behavior can be reproducibly observed (Dubin-Thaler, et 
al., 2008).  In that context, I found that a major defect emerged in the spreading of the 
endoplasm in Fln-depleted MEFs.  As mentioned previously, the endoplasm is the central, 
membranous organelle-rich region of the cell.  A second region, the ectoplasm, surrounds 
the endoplasm and is depleted of organelles due to the presence of a dense actin network 





Figure 11 – Differential interference contrast micrograph highlighting the endoplasm and ectoplasm (Nishizaka, 
Shi, & Sheetz, 2000) 
 
Endoplasmic spreading refers to the flattening and subsequent increase in area of the 
endoplasm during cell spreading.   
Despite hundreds of articles describing the spreading of the cell edge, relatively 
few have approached the subject of endoplasmic spreading, potentially due to a lack of 
systems in which endoplasmic spreading is perturbed.  With this in mind, I focused on 
Fln-depleted MEFs in an effort to elucidate other phenotypes associated with defective 
endoplasmic spreading.  Adhesion maturation/growth emerged as a key process in the 
endoplasmic spreading mechanism, leading us to investigate the role of vimentin 
intermediate filaments in endoplasmic spreading.  Our results implicate all three 




Chapter	  2	  –	  Filamin	  Depletion	  Blocks	  Endoplasmic	  Spreading	  and	  
Destabilizes	  Force-­‐Bearing	  Adhesions	  (Lynch,	  et	  al.,	  2011)	  
 
2.1	  -­‐	  Depletion	  of	  FlnA	  in	  FlnB-­‐/-­‐	  MEFs	  Causes	  a	  Spreading	  Defect	  
 
FlnA levels were knocked down by transfecting FlnB -/- MEFs with an 
expression vector for FlnA-targeting shRNA, GFP, and a puromycin resistance sequence. 
A non-targeting shRNA was similarly expressed as a negative control.  GFP-expressing 
cells transfected with either vector were sorted from untransfected cells by fluorescence 
activated cell sorting (FACS) and subsequently lysed for Western blot analysis.  Cells 
expressing the FlnA-targeting sequence showed an average of ~75% knockdown when 
compared to controls (Figure 12A).  Additionally, representative immunofluorescence of 
the GFP-expressing cells with an antibody to FlnA showed an ~ 80-85% depletion of 
FlnA levels compared to controls in the same field (Figure 12D).  
These Fln-depleted MEFs exhibited a spreading defect in that the central 
organelle-rich region was confined to a smaller area than controls (Figure 12B). Further, 
the level of knockdown correlated with the level of condensation of the organelle rich 
region (Figure 12D).  The phenotype was rescued by expression of human FlnA-GFP in 
Fln-depleted MEFs (Figure 12C).  Also, Fln-depleted MEFs exhibited a thicker central 
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region than controls (Figure 12E) by approximately a factor of 2 (Figure 12F). 
 
Figure 12 – Fln depletion causes an early endoplasmic spreading defect (Lynch, et al., 2011) 
	  
2.2	  -­‐	  Fln	  Depletion	  Blocks	  Spreading	  of	  the	  Endoplasm	  from	  the	  Initiation	  of	  
Spreading	  
 
 The spreading defect associated with Fln depletion appeared to be affecting the 
spreading of the endoplasm, a region previously described as the slightly raised region 
near the cell center containing the majority of membrane-bound organelles and 
(A) Western blot of FlnB–/– MEFs transfected with nontargeting or FlnA-targeting shRNA vectors expressing GFP 
sorted from untransfected cells by FACS. FlnA levels were reduced 73% ± 5% (SEM) compared with the control 
(n = 3). (B) Cell lines were spread on FN-coated glass for  45 min and imaged. Endoplasmic regions are smaller in 
Fln-depleted MEFs compared with controls. Dotted red lines indicate endoplasmic regions. Scale = 20 μm. (C) 
Human FL FlnA-GFP rescued the endoplasmic spreading defect when transfected into Fln-depleted MEFs. Scale = 
20 μm. (D) Fln-depleted MEFs (cell on left) exhibited an early spreading defect of the endoplasm when spread on 
10 μg/ml FN-coated glass. Scale = 20 μm. The cells were fixed and immunostained for FlnA, resulting in 
correlation of GFP expression with FlnA knockdown and the endoplasmic spreading defect. (E) Fln-depleted and 
negative control MEFs were plated on 10 μg/ml FN-coated glass for 40 min and fixed. Cells were verified for GFP 
expression, treated with FM4-64 at 5 μg/ml in PBS for at least 5 min and imaged. Scale = 10 μm. Confocal z-scan 
along the x-axis of cells shown exhibits disparate thickness of endoplasmic region between Fln-depleted and 
control MEFs. Scale = 10 μm on both axes. (F) Quantification of cell heights over three separate experiments, at 
least 15 cells counted for cell type, ***p < 0.001, error bars = standard error (SE). 
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surrounded by the ectoplasm, the peripheral region of dense actin arrays that exclude 
organelles (Nishizaka, Shi, & Sheetz, 2000).  However, to confirm the molecular nature 
of this region I transfected Fln-depleted MEFs and controls with a construct expressing 
an RFP-tagged endoplasmic reticulum (ER) marker, namely the calreticulin ER targeting 
sequence and the KDEL retention sequence.  Fixation of transfected cells showed a 
smaller ER area in Fln-depleted MEFs (Figure 13B) compared to controls (Figure 13A).  
 
Figure 13 - Fln depletion results in a reduction of ER spread area (Lynch, et al., 2011) 
 
Because ER area is highly dependent on overall cell area, I measured the ratio of 
fluorescent ER area to DIC whole cell area to determine the percentage of total area 
occupied by the ER.  Fln-depleted MEFs exhibited an approximately 40% decrease in 
(A) FlnB–/– MEFs transfected with negative control shRNA vector and RFP-ER were plated on FN-coated glass 
for 30 min and fixed. GFP signal served as a marker for shRNA transfection. Scale = 20 μm. (B) Same as in A, but 
transfected with FlnA-targeting shRNA. (C) ER area was measured by either RFP signal or DIC and normalized to 
the whole cell area as measured by DIC (***p < 0.001, n = 44). (D and E) Time-lapse images of negative control 
and Fln-depleted MEFs on FN. Scale = 20 μm. (F) Normalized endoplasm area over time (n = 8, p < 0.001), all 
error bars = SE. 
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normalized ER area compared to controls (Figure 13C), confirming that Fln depletion 
causes a spreading defect of the ER. Importantly, I observed no significant difference 
between the area of Fln-depleted MEFs and controls while the difference in ER areas was 
significant, even before normalization.  Additionally, the vesicle-rich endoplasm was 
measured using video-enhanced DIC and the area of the endoplasm was equal to the area 
of the ER (Figure 13C), showing that using DIC micrographs alone was suitable for 
analyzing ER area. 
When viewed from early times in spreading, Fln-depleted MEFs often had a 
particularly granular appearance in the periphery and showed increased ruffling (Figure 
13E) when compared to controls (Figure 13D).  The endoplasm also failed to spread.  
Normalized endoplasm areas for Fln-depleted cells were significantly decreased 
compared to controls independent of the time of spreading (Figure 13F).  
 
2.3	  -­‐	  Microtubules	  are	  confined	  in	  Fln-­‐depleted	  MEFs	  
 
Because restriction of the ER to the cell center may result from the restriction of 
microtubules (MTs) (Waterman-Storer & Salmon, 1998), I stained Fln-depleted MEFs 









MTs in Fln-depleted MEFs were confined to the cell center compared to untransfected 
cells in the same field (Figure 14B).  When the distance between the MT boundary and 
the cell edge was quantified, the MT boundary was twice as far from the edge in Fln-
depleted MEFs as in controls in both TIRF and epifluorescence (Figure 14C, D). To 
determine if MTs were only partially extending or if they were extending then retracting, 
I tracked MTs using fluorescent ensconsin (3xEMTB-GFP).  MTs were constrained and 
did not extend to the cell edge from early times (Figure 14E, F).   
MT restriction can occur due to either MT stabilization or abnormally rapid actin 
rearward flow.  To determine if MTs had become stabilized, time-lapse observations of 
EB3-RFP were performed.  MTs in the Fln-depleted system exhibited lower growth rates 
than controls during the first 30 minutes of spreading (Figure 14G).  Also, 50 µM 
blebbistatin treatment rescued Fln-depleted MT growth rates (Figure 14G).  Additionally, 
actin rearward flow rates were measured from spreading initiation and during late 
spreading (> 30 minutes) using LifeAct-Ruby.  Rearward flow rates were significantly 
(A) FlnB–/– MEFs treated with FlnA shRNA were spread for 1 h on FN-coated glass, fixed, and stained for MTs. 
GFP-expressing cells were considered transfected and therefore Fln-depleted. Red lines demarcate cell edges. Scale 
= 50 μm.(B) Enlarged regions from A showing that Fln-depleted MEFs exhibit a larger distance between the MT 
boundary and the cell edge than do controls. (C) Quantification of distance from MT boundary to cell edge in Fln-
depleted MEFs and controls after 15 min of spreading on FN-coated glass measured in TIRF (at least 10 
measurements per cell, n = 3) (***p < 0.001). (D) Quantification of distance from MT boundary to cell edge in Fln-
depleted and controls after 30 min of spreading on FN-coated glass measured with epifluorescence (at least 10 
measurements per cell, n = 33) (***p < 0.001). (E) Fln-depleted MEFs and controls were transfected with 3x-
ensconsin-GFP, allowed to spread, and imaged in TIRF. (F) Kymographs taken along white lines from E show a 
persistently larger distance between the MT boundary and the cell edge in Fln-depleted MEFs compared with 
controls.(G) Quantification of MT dynamics during the first 30 min of spreading by assessing EB3-RFP growth 
velocity. Fln-depleted MEFs exhibited slower MT extension than controls (multiple measurements per cell,  n = 10 
cells) (***p < 0.001), whereas 50 μM blebbistatin treatment rescued this phenotype (multiple measurements per 
cell, n = 7 cells) (***p < 0.001). (H) Quantification of actin rearward flow velocities by assessing LifeAct-Ruby 
dynamics from the initiation of spreading. Kymographs of Fln-depleted MEFs showed slower rearward flow than 
controls (multiple kymographs per cell, n = 6 cells/line) (***p < 0.001). (I) Rearward flow velocities gathered from 
cells spread for at least 30 min. Fln-depleted MEFs show no significant difference from controls (n = 11 cells/line), 
all error bars = SE. 
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slower in Fln-depleted MEFs at early time points (Figure 14H), while at later times there 
was no difference between Fln-depleted and controls (Figure 14I).   
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2.4	  -­‐	  Focal	  adhesions	  are	  small,	  transient,	  and	  unable	  to	  support	  edge	  extension	  
in	  Fln-­‐depleted	  MEFs	  
 
MT targeting is believed to be involved in focal adhesion dynamics (Krylyshkina, 
et al., 2003) (Krylyshkina, et al., 2002) (Kaverina, Krylyshkina, & Small, 1999).  Since 
MTs do not extend to the periphery in Fln-depleted cells, peripheral focal adhesions may 
also be altered.  To test this possibility, Fln-depleted MEFs and untransfected controls 
were spread for one hour and stained with anti-paxillin antibodies and phalloidin (Figure 
15B). Fln-depleted cells exhibited small foci of paxillin accumulation and a disorganized 
actin cytoskeleton that was deficient in stress fibers compared to untransfected controls in 
the same field (Figure 15C).   
 




Since these controls were in fact FlnB -/- MEFs, it was important to examine FlnA 
localization in wild-type cells.  I observed FlnA enrichment in several cytoskeletal 
structures, including transverse arcs surrounding the endoplasm, nodes of crosslinking 
connecting mature stress fibers extending above the endoplasm to the transverse arc ring 
below, as well as at the leading edge and the trailing ends of mature focal adhesions 
(Figure 15A).  The smaller adhesions in Fln-depleted MEFs could be a result of less β1 
integrin expression, however this was found not to be the case (Figure 15D).   
Because smaller adhesions could be explained by a deficiency in focal adhesion 
formation or unstable focal adhesions, I transfected Fln-depleted MEFs with paxillin-RFP 
and found that these cells formed focal contacts, but over time, these contacts were 
unstable and were disassembled (Figure 15E, F).  When the lifetime of the contacts was 
measured for the Fln-depleted cells after onset of contraction, paxillin-RFP contacts had a 
much shorter lifetime (~8.5 minutes s.e.m. = 0.05 minutes, n = 45) compared to control 
adhesions that outlasted the time course of the experiment (> 15 minutes).  These results 
indicated that adhesions in Fln-depleted MEFs are more dynamic than controls. Because 
this suggests that these adhesions would not be able to support high levels of force, I 
induced contraction with the MT polymerization inhibitor nocodazole (Kolodney & 
(A) Merged confocal sections of FlnB+/+ MEF 30 min after plating on FN-coated glass. Scale = 20 μm; green = 
paxillin, red = phalloidin, blue = FlnA). Enlarged regions highlight areas of FlnA enrichment, including large nodes 
at stress fiber junctions, the cell edge, adhesions, and transverse arcs surrounding the endoplasm. (B) FlnB–/– 
MEFs treated with FlnA shRNA were spread for 1 h on FN-coated glass, fixed, and stained for paxillin and 
phalloidin. GFP-expressing cells were considered transfected and therefore Fln-depleted. Scale = 50 μm.  (C) 
Merged images of paxillin and F-actin panels show that Fln-depleted MEFs exhibited a highly disorganized, stress 
fiber-free, actin meshwork surrounding the endoplasm as well as a lack of focal adhesions compared with 
nontransfected cells. Scale = 50 μm; green pseudocoloring = paxillin, magenta = phalloidin). (D) FlnB–/– MEFs 
were transfected with nontargeting or FlnA-targeting shRNA expression vectors, sorted by FACS, and lysed. GFP-
expressing cells from these populations exhibit no difference in β1 integrin expression. (E) Fln-depleted MEFs and 
controls expressing paxillin-RFP were spread on FN-coated glass and imaged with TIRF microscopy. Scale = 5 
μm. 
(F) Kymographs taken along white lines in E show that focal adhesions do not 
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Elson, 1995).  Fln-depleted MEFs showed more rapid retraction of edge contacts and 
lamellipodial extensions whereas controls maintained even narrow extensions (Figure 
15G). 
2.5	  -­‐	  High	  Forces	  Are	  Generated	  in	  Fln-­‐depleted	  MEFs	  but	  Rapidly	  Release	  
 
Because unstable focal adhesions could result in defects of force generation, I 
measured the traction forces of Fln-depleted MEFs using an array of 
polydimethylsiloxane (PDMS) pillars (Tan, Tien, Pirone, Gray, Bhadriraju, & Chen, 
2003) (du Roure, et al., 2005).  When Fln-depleted MEFs were spread and imaged on 
PDMS pillars for ~ 30 minutes, they exhibited more narrow extensions than controls 
(Figures 16A, B).   
 
Figure 16 - Fln-depleted MEFs exhibit an inability to sustain large, controlled forces on FN-coated pillars 




Representative force vs. time traces from single pillar measurements exhibited 
similar or higher levels of peak force generation (Figures 16C, D), however the release of 
force occurred at a higher rate in Fln-depleted cells when compared to controls (Figure 
16E).  In Fln-depleted cells, the average rate of force release was nearly four times that of 
the control (Figure 16F).  Because this behavior could result from impaired traction force 
generation, I measured whole-cell force generation and found a slightly lower traction 
force per pillar in Fln-depleted MEFs, but the average value was not significantly 
different from controls (Figure 16G).   
2.6	  -­‐	  FlnA-­‐/-­‐	  Cells	  Have	  Many	  Characteristics	  of	  Fln-­‐depleted	  Cells	  
 
Given the dramatic motility defects in Fln-depleted MEFs, I asked whether these 
phenotypes could be attributed to either FlnA or FlnB.  FlnA -/- MEFs exhibited a weaker 
ER spreading deficiency than Fln-depleted MEFs (Figure 17A) while FlnB -/- MEFs 
appeared very similar to controls (Figure 12B).  Averaged normalized ER areas of FlnA -
/- (Figure 17B) but not FlnB -/- MEFs, were significantly decreased when compared to 
(A and B) Fln-depleted MEFs and controls were spread on FN-coated PDMS pillars for ∼30 min. Scale = 20 μm. (C 
and D) Representative traces of single pillar movements tracked over ∼30 min of spreading in control (C) and Fln-
depleted (D) MEFs (traces taken from pillars marked by a red dot in A and B). (E) Colored regions from C and D 
reveal rapid force release in Fln-depleted MEFs compared with controls. (F) Average rate of force-release events 
on pillars. Fln-depleted MEFs exhibited a significantly higher rate of force release compared with controls (5.42 
pN/s ± 1.50 pN/s compared with 1.36 pN/s ± 0.21 pN/s, n = 29, ***p < 0.001). (G) Mean force/pillar of Fln-
depleted MEFs and controls shows no significant difference in force generation capability (n = 12; >3 





Figure 17 - FlnA is the major Fln isoform involved in endoplasmic spreading defects (Lynch, et al., 2011) 
 
Also, while FlnA -/- MEFs form stress fibers late in spreading, it was common for them 
to experience a contraction of the endoplasm that was not seen in controls or Fln-depleted 
MEFs.  This contraction was often associated with stress fiber breakage and the 
appearance of gaps at the endoplasm boundary of FlnA -/- MEFs (Figure 17C), 
suggesting that the cytoskeleton network was formed but was not able to sustain force at 
the endoplasm boundary.  Stress fiber breakage was correlated with endoplasm retraction 
(Figure 17D) and gaps in the cytoplasm were observed at the endoplasm boundary of 
FlnA -/- MEFs (Figure 17E) during the contractile phase of spreading (Figure 17F). 
(A) Representative montages of single FlnA+/+ and FlnA–/– MEFs spread for 25 min on FN (red dotted lines 
demarcate endoplasm regions). (B) Averaged normalized endoplasm areas for each cell line represented in A. Data 
shown are mean ± SEM (n = 17). Differences were significant throughout the time course (p < 0.001, two-way 
repeated measures ANOVA). (C) FlnA–/– MEF spread on FN-coated glass for 50 min. Scale = 20 μm. (D) 
Montage of stress fiber demarcated in C. After stress fiber breakage, the endoplasm is contracted rearward as 
indicated by red dotted line. (E) Enlarged images demarcated in A. Gaps are seen in ii., with a normal, coherent 
ectoplasm shown in i. for comparison. (F) Kymographs from lines seen in E. Gaps begin to appear 15 min after the 
initiation of spreading and persist throughout. Scale: 10 μm and 10 min, all error bars = SE. 
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2.7	  -­‐	  Endoplasmic	  spreading	  requires	  the	  calpain-­‐cleavability	  and	  integrin-­‐
binding	  functions	  of	  FlnA	  
 
To further understand Fln’s role in the Fln-depleted endoplasmic spreading 
phenotype, Fln-depleted MEFs were transfected with RFP-ER and human full-length 
(FL) FlnA, calpain-uncleavable FlnA, or FlnA Δ19-21, the latter missing the primary 
integrin-binding site of FlnA.  
 
Figure 18 - Calpain cleavability and integrin-binding are FlnA functions critical in the ER spreading phenotype 
(Lynch, et al., 2011) 
 
Normalized ER areas showed complete rescue of endoplasmic spreading upon FL FlnA 
addition, while calpain-uncleavable FlnA and FlnA Δ19-21 showed only partial rescue 
(Figure 18), indicating that both integrin binding and calpain cleavage play significant 
roles in Fln organization and function. 
 
2.8	  -­‐	  Summary	  and	  Discussion	  
 
Fln-depleted MEFs were transfected with RFP-ER and FL FlnA, calpain-uncleavable FlnA, or FlnA lacking 
domains 19–21. FL FlnA recovers the ER spreading phenotype to above control levels, whereas calpain-
uncleavable FlnA and FlnA lacking domains 19–21 exhibit only partial recovery (n = 36) (***p < 0.001), all error 
bars = SE. 
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Although previous studies of Fln isoform knockouts or mutants show interesting 
phenotypes (Cunningham, Gorlin, & Kwiatkowski, 1992) (Feng, et al., 2006) (Zhou, et 
al., 2007), the depletion of multiple Flns shows a novel phenotype that has, as yet, not 
been ascribed to the loss of Flns: namely a deficiency in endoplasmic spreading. When 
the spreading of the endoplasm and ectoplasm is coupled, endoplasm area stabilizes at 
50-60% of total cell area in controls (Figure 17B).  The Fln-depleted deficiency in 
endoplasmic spreading results in a reduction of endoplasmic area to ~30% of total cell 
area (as assessed by a fluorescent ER marker) (Figure 13F) and is associated with a 
significant decrease in MT extension rate (Figure 14G).  In addition, Fln-depleted cells 
lack stress fibers and have very dynamic adhesions (Figure 15B, C, E, F).  Although the 
traction forces generated by Fln-depleted cells are only slightly lower than control cells 
(Figure 16G), the rate of loss of tension is dramatically higher indicating that Fln is 
important for maintaining mechanical forces on adhesions (Figure 16F).  These changes 
are consistent with a role for Fln in stabilizing the actin cytoskeleton under force.   
Since the ER typically spreads along MTs, it is expected that the MT arrays are 
condensed in Fln-depleted cells (Figure 14). This condensation was found to be partially 
due to the fact that MTs have lower extension rates in Fln-depleted MEFs than in controls 
(Figure 14G).  Another possibility that has been shown previously (Terasaki & Reese, 
1994) is that MT condensation could be a result of high rates of actin rearward flow 
preventing extension to the periphery.  However, rearward cortical actin flow rates were 
actually lower in Fln-depleted MEFs than in controls during the period when MT 
extension rates were measured (Figure 14H) and not significantly higher than controls 
later in spreading (Figure 14I). We also accounted for the directionality of MT extension 
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in our analysis.  MTs in control cells moved in a vector direction toward the periphery 
whereas MTs in Fln-depleted MEFs were more randomized (data not shown).  However, 
this did not affect our assessment of MT growth rates as we measured the velocity over 
the EB3 distance traveled, not simply the displacement.  The further observation that 
blebbistatin treatment rescues MT condensation in Fln-depleted MEFs (Figure 14G) 
indicates that MT extension is hindered by a contractile actin network surrounding the 
endoplasm that, without Fln crosslinking, is presumably too dense to permit typical MT 
extension.  As a result, MTs in Fln-depleted cells could potentially experience higher 
rates of catastrophe and pauses in growth.   
This raises the question of whether the absence of MTs in the periphery would 
alter adhesion dynamics, membrane traffic or other parameters.  MTs are implicated in 
the process of adhesion turnover but adhesions must form initially for this to occur.  In 
the Fln-depleted cells, there is extensive ruffling of the edge that is indicative of a lack of 
stable adhesions in the periphery as is observed (Figure 15B, C, E, F) and perhaps an 
alteration in the process leading to mature stress fibers (Figure 15B, C) (Hotulainen & 
Lappalainen, 2006).  Further, the inability of the endoplasm to spread appears to precede 
the loss of early adhesions, which indicates that the primary defect is in adhesion 
maturation or in coupling of the microtubule ends to the peripheral adhesions to enable it 
to extend.  
In considering adhesion maturation, it is useful to compare the adhesions that 
form after Fln depletion with the lack of even early adhesions after talin depletion. Fln-
depleted cells formed early adhesions that quickly disassembled as indicated by RFP-
paxillin dynamics (Figure 15E, F).  In contrast, talin-depleted MEFs did not exhibit 
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extensive spreading or adhesion formation (Zhang, Jiang, Cai, Monkley, Critchley, & 
Sheetz, 2008).  I speculate that since Fln depletion appears to reduce the lifetime of 
adhesions, Fln may contribute to stabilization of adhesions and/or maintenance of the 
force-generating actomyosin network.  Indeed, a recent study of Fln ligand-binding sites 
has shown Flns to have the capacity to bind multiple integrin β tails at once, potentially 
allowing Fln to cluster integrins, and thereby replace talin in the formation of mature 
adhesions (Ithychanda, et al., 2009). 
 I found additional evidence that Fln is involved in stabilizing adhesions from the 
dynamics of force generation of Fln-depleted MEFs on PDMS pillars.  Because many in 
vivo environments are discontinuous (there are micron-sized gaps in the cornea (Nishida, 
Yasumoto, Otori, & Desaki, 1988) and the intestinal mucosa (Toyoda, Ina, Kitamura, 
Tsuda, & Shimada, 1997)), PDMS pillar arrays provide a relevant measure of cellular 
forces while still allowing for the accurate quantification of forces exerted by specific 
cellular regions (Tan, Tien, Pirone, Gray, Bhadriraju, & Chen, 2003) (du Roure, et al., 
2005).  The rate of force release on single pillars is ~four-fold higher after Fln depletion 
compared to controls (Figure 16F).  Whole-cell force measurements indicated a trend 
toward lower force exerted / pillar in the Fln-depleted system, though these findings were 
not significant (Figure 16G).  Similar, but stronger results were found using M2 cells 
(Kasza, et al., 2009).  
In the case of Fln-depleted fibroblasts, the presence of early adhesions, high 
traction forces, and rapid force release all indicate that the matrix-integrin linkage to the 
cytoskeleton forms but is not sustained.  As further support of this hypothesis, 
nocodazole treatment causes dramatic collapse of lamellipodial extensions in Fln-
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depleted MEFs (Figure 15G).  Whether the collapse occurs at the level of the adhesion or 
the actin cytoskeleton is a subject for future studies, since Fln has both roles in stabilizing 
the actin cytoskeleton and linking integrins to actin filaments. 	  
In addition to a role in traction force generation, Fln appears to play a structural 
role in stabilizing force-bearing structures within the cytoskeleton, since it is concentrated 
in interior regions of cytoplasm. The primary localization of FlnA is in structures 
surrounding the endoplasm both near the ventral surface and in nodes of cross-linked 
actin as well as in dorsal stress fibers (Figure 15A).  Additionally, Fln appears to be 
found in the proximal regions of focal adhesions (or in stress fibers emerging from focal 
adhesions, though super resolution studies may be necessary to confirm this) (Figure 
15A), suggesting an important role in linking adhesions to the cytoskeleton proper.  
Accordingly, in time-lapse DIC movies of spreading FlnA -/- MEFs, I find stress fiber 
breakage that results in endoplasm retraction (Figure 17D).  I observe breakage events 
near adhesive contacts as well as in the middle of stress fibers, suggesting that the 
inability to sustain high levels of local force generation in Fln-depleted MEFs could be a 
result of weakness in both the dynamic actin cytoskeleton and the connections to 
adhesions.   
It is logical that Flns may stabilize the structural linkages by spreading force 
among multiple actin filaments in dynamic cytoskeletal links within the actin network 
surrounding the endoplasm, in stress fibers, and in force-generating contacts on pillars.  
The observation that calpain-uncleavable FlnA and FlnA Δ19-21 do not completely 
rescue the endoplasmic spreading deficiency (Figure 18) supports this notion.  In addition, 
Fln has an affinity for the membrane, as shown through the well-characterized blebbing 
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of M2 melanoma cells (Cunningham, Gorlin, & Kwiatkowski, 1992).  Gaps in the 
membranes of FlnA-/- cells are indicative of that role as well (Figure 17C, E, F).   








Figure 19 – Schematic model of endoplasmic spreading (Lynch, et al., 2011). 
 
During the initial phases of spreading (P0 and P1), the cortical cytoskeleton is flattened, 
which will cause the endoplasm to flatten as well.  Upon the activation of contraction 
(P2), the endoplasm will spread because of forces developed on the peripheral adhesions.  
In the absence of Fln, both mechanisms of spreading are weakened because of the loss of 
crosslinks in the actin network.  Connections between the endoplasm and surrounding 
cortical actin are particularly sensitive, explaining why gaps in the membrane form in this 
region in the FlnA-/- cells and why there are abrupt retractions of the endoplasmic 
boundary (Figure 17D). High forces generated within the contractile actin network 
surrounding the endoplasm that are normally transmitted through these connections 
would resist extension of MTs and the endoplasm boundary with the cell edge.  This is 
still the case when calpain uncleavable FlnA and FlnA Δ19-21 are added to the Fln-
depleted system, underlining the importance of the Fln-adhesion linkage as well as the 
dynamic nature of actin crosslinks (Figure 18). 
Additionally, it should be noted that while our study concentrates on Fln-depleted 
and FlnA -/- MEFs, FlnB -/- MEFs did exhibit similar but less severe phenotypes.  I 
suggest that the endoplasmic spreading deficiency that I report may be caused by a 
general Fln deficiency, rather than a deficiency of FlnA or FlnB specifically.  Indeed, 
Initially the cell begins to spread via actin polymerization against the cell membrane. Cortical actin is cross-linked 
by Fln along the membrane. As the cell continues to spread, actin polymerization forces at the edge are transmitted 
back through the Fln-cross-linked cortex to the cell center, causing flattening of the endoplasm. At the same time, 
early adhesions begin to form. At the onset of contraction, cells exert contractile forces through mature focal 
adhesions, Fln-bundled actin stress fibers, and Fln-cross-linked actin meshworks (not shown for simplicity), 
allowing the endoplasm to spread in the direction of the edge despite being already flattened. Fln-depleted MEFs 
do not exhibit endoplasmic compression because they lack cortical cross-linking while they also do not experience 
contractile endoplasmic spreading due to unstable focal adhesions and a lack of strong actin stress fibers and cross-
linked actin capable of stably supporting large forces exerted on the substrate. 
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FlnA and FlnB show high homology (van der Flier & Sonnenberg, 2001) while FlnA 
typically comprises ~60% of expressed Flns in fibrosarcoma cells (Baldassarre, Razinia, 
Burande, Lamsoul, Lutz, & Calderwood, 2009), indicating that loss of FlnA has a greater 
impact on cellular Fln levels than FlnB loss.  FlnC undoubtedly plays a role as well, since 
FlnC’s expression is increased upon depletion of FlnA and FlnB in fibrosarcoma cells 
(Baldassarre, Razinia, Burande, Lamsoul, Lutz, & Calderwood, 2009).  Nonetheless, total 
Fln levels are lower in doubly depleted cells than in single knockdowns and controls, 
indicating that the endoplasmic spreading deficiency truly is linked to low levels of Fln 
expression. 
In summary, I suggest that the primary role of Flns during cell spreading is to 
stabilize the transmission of forces through adhesions to cross-linked and bundled actin 
structures to enable formation of a cohesive cytoskeleton that supports endoplasmic 
spreading and organelle dispersal. Although Fln itself may have no direct role in bearing 
tensile forces, its depletion results in major cytoskeletal disruptions as cells generate 
force.  Further, Flns stabilize stress fibers and the actin cytoskeleton linkages to focal 
adhesions and membranes.  Thus, I suggest that the endoplasmic reticulum- and 
microtubule-rich cytoplasm behaves as a separate mechanical unit that is contractile and 




Chapter	  3	  –	  Endoplasmic	  spreading	  requires	  interaction	  between	  vimentin	  
intermediate	  filaments	  and	  force-­‐bearing	  focal	  adhesions	  (Lynch,	  et	  al.,	  in	  
preparation)	  
 
3.1	  -­‐	  ALLN	  restores	  focal	  adhesion	  maturation	  and	  endoplasmic	  spreading	  in	  
Fln-­‐depleted	  MEFs	  
 
Recent studies indicated a role for FlnA in stabilizing focal adhesions, since FlnA 
depletion leads to increased rates of disassembly (Xu, et al., 2010)  (Lynch, et al., 2011).  
The turnover appeared to be protease dependent, since the calpain inhibitor N-[N-(N-
Acetyl-L-leucyl)-L-leucyl]- L-norleucine (ALLN) reversed the increased rates of 
adhesion turnover in Fln-depleted cells and subsequently restored adhesion maturation 
(Xu, et al., 2010).  Therefore, we tested if ALLN would restore adhesions in Fln-depleted 
MEFs.  Expression of full-length (FL) FlnA restored normal FAs in Fln-depleted MEFs 
that had smaller adhesions (Figure 20A).  Addition of ALLN similarly restored normal 
FAs. (Figure 20A).  Quantification showed that adhesion area in Fln-depleted MEFs was 
increased two-fold by expressing FL FlnA, and three-fold by ALLN treatment (Figure 
20B).  Adhesion maturation occurred primarily during P2 of cell spreading (Dobereiner, 
Dubin-Thaler, Giannone, Xenias, & Sheetz, 2004) (Figure 20C), similar to untreated 
wild-type (WT) MEFs.  If increased turnover of adhesions was linked to the Fln-depleted 
endoplasmic spreading defect, then treatment of Fln-depleted MEFs with ALLN should 
restore endoplasmic spreading. 
Although differential interference contrast (DIC) micrographs of Fln-depleted 
MEFs showed a dense endoplasm clustered near the center of the cell, treatment with 
ALLN caused the endoplasm to spread normally (Figure 20D).  Accordingly, the 
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endoplasm/whole cell area ratio, measured as described previously (Lynch, et al., 2011), 
 
Figure 20 - ALLN rescues endoplasmic spreading in Fln-depleted MEFs (Lynch, et al., in preparation) 
 
of Fln-depleted MEFs was increased to control levels by treatment with ALLN compared 
to untreated Fln-depleted MEFs (Figure 20E).  This effect was observed within 3-5 
minutes of ALLN addition (Figure 20F).  Taken together, these results indicate that the 
A) Fln-depleted MEFs were treated with 50 µM ALLN or an equal volume of DMSO for 22 hours, plated on 10 
µg/ml fibronectin (FN)-coated glass for 30 minutes, fixed, stained for paxillin, and imaged with confocal 
microscopy.  GFP signal was associated with successful FlnA shRNA transfection and expression.  B) Areas of 
adhesion plaques were measured manually from a single confocal slice in each condition (Fln-depleted w/FL FlnA: 
7 cells, 128 adhesions; Fln-depleted w/DMSO: 10 cells, 305 adhesions; Fln-depleted with ALLN: 12 cells, 323 
adhesions; *: p < 0.001).  C) Adhesion areas were measured at various time points using the same method as in B 
(w/DMSO, 10 minutes: 6 cells, 39 adhesions; w/DMSO, 20 minutes: 15 cells, 174 adhesions; w/DMSO, 30 
minutes: 12 cells, 198 adhesions; w/ALLN, 10 minutes: 16 cells, 295 adhesions; w/ALLN, 20 minutes: 9 cells, 168 
adhesions; w/ALLN, 30 minutes: 10 cells, 213 adhesions).  D) Fln-depleted MEFs were transfected with RFP-ER, 
treated with 50 µM ALLN or an equal volume of DMSO for 22 hours, plated on FN-coated glass for 30 minutes, 
and fixed.  E) Endoplasm/whole cell area was determined by measuring RFP-ER area and whole cell area in 
fluorescent and DIC channels respectively (w/ FL FlnA: 34 cells; w/DMSO: 40 cells; w/ALLN: 41 cells; *: p < 
0.001).  F) Fln-depleted MEFs were plated on FN-coated glass followed by addition of either DMSO or ALLN into 
the media, all error bars = SE. 
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defect in focal adhesion maturation was correlated with the endoplasmic spreading 
deficiency previously reported in Fln depleted MEFs. 
 
3.2	  -­‐	  Expression	  of	  a	  low-­‐turnover	  talin	  variant	  rescues	  endoplasmic	  spreading	  
in	  Fln-­‐depleted	  MEFs	  
 
Because calpain-mediated proteolysis is a rate-limiting step in focal adhesion 
turnover (see section 1.8), preventing talin cleavage may promote adhesion growth and 
endoplasmic spreading.  To test this possibility, I transfected Fln-depleted MEFs with the 
GFP-calpain-uncleavable talin (NC Talin) that can stabilize adhesions for further 
maturation (Franco, et al., 2004).  
  
Figure 21 – Expression of a low-turnover talin variant rescues endoplasmic spreading in Fln-depleted MEFs 








In Fln-depleted MEFs, expression of NC Talin restored endoplasm spreading whereas 
expression of FL Talin had no effect (Figure 21A).  Endoplasm/whole-cell area ratios 
measured in Fln-depleted MEFs expressing NC Talin were indistinguishable from the 
Fln-depleted MEFs expressing FL FlnA (Figure 21B).  Like Fln-depleted MEFs treated 
with ALLN, expression of NC Talin produced more elongated and mature adhesions than 
did expression of FL Talin (Figure 21C).  Likewise, adhesion area was significantly 
greater in Fln-depleted MEFs transfected with NC Talin compared to Fln depleted MEFs 
with or without FL Talin (Figure 21D) and adhesion growth showed a similar trend 
(Figure 21E).  Thus, inducing adhesion maturation using two distinct approaches, ALLN 
treatment and NC Talin expression, rescued Fln-depleted endoplasmic spreading. 
 
3.3	  -­‐	  Endoplasmic	  spreading	  requires	  vimentin	  intermediate	  filaments	  
 
Because adhesions associated with vimentin intermediate filaments (vIFs) tend to 
be larger and more stable (Burgstaller, Gregor, Winter, & Wiche, 2010) (Tsuruta, 2003), 
I investigated the role of vIFs in endoplasmic spreading.  I transfected RPTPα +/+ MEFs 
with either a full-length vimentin-GFP construct (GFP-FL Vim) or a GFP-tagged 
dominant negative vimentin variant expressing only amino acids 1-138 (GFP-Vim 1-138) 
(Chang, et al., 2009).  These amino acids only code for the vimentin globular head 
A) Fln-depleted MEFs were co-transfected with GFP-tagged talin, either full-length (FL) or calpain 
uncleavable (NC), spread for 30 minutes and fixed.  B) Endoplasm/whole cell area ratios were measured 
using differential interference contrast (DIC) images for Fln-depleted MEFs co-transfected with GFP-
tagged FL FlnA, FL talin, or NC talin (at least 17 cells analyzed/experimental condition; * : p > 0.1, ** : p 
< 0.001).  C) Fln-depleted MEFs, expressing mCherry as an shRNA marker, were co-transfected with GFP-
tagged FL or NC talin, spread on FN for 30 minutes, fixed, and stained for paxillin.  D) Areas of adhesion 
plaques were measured manually from a single confocal slice in each condition (Fln-depleted w/FL FlnA: 7 
cells, 128 adhesions; Fln-depleted: 10 cells, 305 adhesions; Fln-depleted w/ FL Talin: 11 cells, 166 
adhesions; Fln-depleted w/ NC Talin: 5 cells, 82 adhesions; *: p > 0.1, **: p < 0.01).  E) Fln-depleted 
MEFs transfected with either FL or NC Talin were allowed to spread and fixed at various time points 
(min.).  Cells were stained for paxillin and adhesion area was measured as in D, all error bars = SE. 
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domain and a small portion of the α-helical rod domain, so their incorporation into 
growing vIFs halts elongation.  Spread cells expressing GFP-Vim 1-138 lacked 
polymerized vIFs compared to controls expressing GFP-FL Vim (Figure 22A).  Similar 
to the Fln-depleted system, cells expressing GFP-Vim-1-138 were unable to spread the 
endoplasm (Figure 22A) and had endoplasm/whole cell area ratios that were significantly 
lower than controls (Figure 22C).  FAs were also smaller, more punctate, and failed to 
mature as in Fln-depleted MEFs (Figure 22B, E), resulting in adhesion areas that were 
significantly less than controls (Figure 22D).  Together, these results demonstrated 
marked phenotypic similarities between the Fln-depleted system and cells expressing 
GFP-Vim 1-138 and indicated that vIFs were required for endoplasmic spreading. 
 
3.4	  –	  Both	  vimentin	  intermediate	  filaments	  and	  mature	  focal	  adhesions	  are	  
required	  for	  endoplasmic	  spreading	  
 
Since expression of GFP-Vim 1-138 inhibited FA maturation as well as vIF 
assembly, there was a question of whether both or only one of these factors was sufficient 
for endoplasmic spreading.  However, Fln-depleted MEFs have vIFs with a contracted 
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endoplasm, indicating that vIFs are not sufficient for endoplasmic spreading.  
 
Figure 22 – Vimentin intermediate filaments and mature focal adhesions are required together for endoplasmic 






To determine if mature FAs are sufficient for endoplasmic spreading in the absence of 
vIFs, I transfected wild-type MEFs with GFP-Vim 1-138 and treated them with ALLN 
overnight. After spreading on FN-coated glass, vIFs did not form (Figure 22A), but 
A) RPTPα +/+ MEFs were transfected with full-length vimentin-GFP or vimentin 1-138-GFP, spread for 
30 minutes on FN-coated glass, and fixed.  vIFs are do not polymerize in the latter condition.  B) RPTPα 
+/+ MEFs were transfected and spread as in A, with subsequent immunostaining for paxillin.  C) 
Endoplasm/whole cell ratios were measured as in Figure 2B (RPTPα +/+: 30 cells, w/FL Vim: 39 cells, 
w/Vim1-138: 30 cells, w/Vim1-138 + ALLN: 45 cells; *: p < 0.001, **: p > 0.1).  D) Adhesions areas were 
measured manually from a single confocal slice in each condition (w/FL Vim: 6 cells, 120 adhesions; w/ 
Vim1-138: 6 cells, 120 adhesions; w/ Vim1-138 + ALLN: 9 cells, 222 adhesions; *: p < 0.001).  E) 
Adhesion plaque areas were measured at various time points using the same method as in D (w/FL Vim: 10 
min: 4 cells, 42 adhesions; 20 min: 6 cells, 114 adhesions; 30 min: 170 adhesions; w/Vim1-138: 10, 20, 30 
min: 5 cells each, 100 adhesions each), all error bars = SE. 
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adhesions matured (Figure 22B, D, E).  Interestingly, the endoplasm did not spread 
(Figure 22A) and endoplasm/whole cell area ratios were unchanged from the GFP-Vim 
1-138-expressing cells without ALLN (Figure 22C).  Thus, mature FAs were not 
sufficient for endoplasmic spreading.  Both vIFs and mature FAs were needed for 
endoplasmic spreading to occur. 
 
3.5	  -­‐	  Vimentin	  intermediate	  filaments	  and	  mature	  focal	  adhesions	  must	  co-­‐
localize	  for	  efficient	  endoplasmic	  spreading	  
 
If endoplasmic spreading required both vIFs and mature FAs, then it followed that 
the two might be physically linked during the endoplasmic spreading process.  In control 
cells transfected with paxillin-GFP and stained for vimentin, vIFs coalesced at FA sites in 
a directed fashion (Figure 23E) and vIFs contacted a high percentage of total FAs (Figure 
23D).  In Fln-depleted cells, vIFs extended into the periphery, without linking to FAs 
(Figure 23E) and only ~35% of FAs in Fln-depleted MEFs were in contact with vIFs 
(Figure 23D).  To further test the role of vIFs, I treated RPTPα +/+ MEFs with 
Withaferin A (WFA), an inhibitor of vimentin cytoskeleton spreading that allowed vIFs 
to form while blocking their extension to the periphery (Thaiparambil, et al., 2011).  In 
WFA-treated cells, vIFs formed but were restricted to the perinuclear region (Figure 23A, 
E) with no discernible changes in the actin cytoskeleton (Figure 23A).  As in Fln-





Figure 23 – Endoplasmic spreading requires co-localization of vimentin intermediate filaments and mature focal 





Intriguingly, WFA-treated cells also showed a defect in adhesion maturation (Figure 23E) 
and an unspread endoplasm (Figure 23B) with endoplasm/whole cell area ratios that were 
approximately 30% lower than controls (Figure 23C).  Thus, under several different 
conditions, endoplasmic spreading was correlated with a high level of co-localization 
A) RPTPα +/+ MEFs were treated with 500 nM withaferin A (WFA) overnight, spread on FN-coated glass 
for 30 minutes, fixed, and stained for vimentin, and subsequently subjected to fluorescent confocal imaging 
(green: anti-vimentin, red: phalloidin).  B) Cells were treated with WFA as in A, fixed, and imaged with 
DIC.  C) Endoplasm / whole cell area ratios were significantly lower for cells treated with WFA than 
controls (30 cells measured for each condition, p < 0.001).  D) Each cell type was plated on FN-coated 
glass for 30 minutes, fixed, and stained for vimentin and paxillin.  FA plaques co-localizing with vIF tips 
were quantified as a percentage of total FA plaques (Cont.: 8 cells, Fln-depleted: 4 cells, Cont. w/ DMSO: 
6 cells, Cont. w/ WFA: 7 cells; *: p < 0.001).  E) Sample images used to generate D.  Cells were prepared 
as described in D and subjected to confocal imaging, all error bars = SE. 
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between vIFs and mature FAs.  Cells deficient in either component or missing an 
interaction between them were unable to spread the endoplasm. 
 
3.6	  –	  In	  Fln-­‐depleted	  MEFs,	  vIFs	  extend	  past	  FAs	  in	  a	  microtubule-­‐dependent	  
manner	  	  
 
Because there appeared to be a need for a linkage between vIFs and FAs, we 
carefully examined vIF distribution in Fln-depleted MEFs and their controls.  Fln-
depleted MEFs had a more extensive vIF network covering a larger fraction of the cell 
area compared to controls (Figure 24A).  The average distance between the cell edge and 
areas containing vIFs was nearly half that of controls in Fln-depleted MEFs (Figure 24B).  
Much of the vIF network extended to regions without FAs in the absence of Fln.  
Nocodazole, the MT polymerization inhibitor, reversed this phenotype (Figure 24A), 
causing confinement of vIFs to the cell center and increasing the distance between vIFs 
and the cell edge (Figure 24B).  Thus, miss targeting and over-extension of vIFs in Fln-




Figure 24 - VIFs extend closer to the cell edge in Fln-depleted MEFs in a microtubule-dependent manner (Lynch, 




A) In each condition, MEFs were plated on FN-coated glass for 30 minutes, fixed, and stained for vimentin 
and phalloidin, with GFP signal corresponding with shRNA expression.  Cells treated with nocodazole 
were exposed 30 minutes prior to spreading.  Vimentin signal was overexposed in all images to highlight 
vIFs in the periphery.  B) Distances of vIFs to the cell edge was determined by averaging the distance from 
the vIF boundary to the cell edge at ten points in the cell, using at least six cells per cell type (*: p < 0.001, 




3.7	  -­‐	  Endoplasmic	  spreading	  requires	  myosin	  II	  contractile	  activity	  
 
Lastly, I sought to determine if contraction plays a role in endoplasmic spreading.  
I allowed RPTPα +/+ MEFs to spread in the presence of blebbistatin, a myosin II 
inhibitor (Straight, et al., 2003), and found that the endoplasm was not spread after 30 
minutes (Figure 25A). 
   
Figure 25 – Endoplasmic spreading requires myosin II-mediated contraction (Lynch, et al., in preparation) 
 
 
A) RPTPα +/+ MEFs were treated with 50 µM blebbistatin or an equal volume of DMSO and plated on 10 
µg/µl FN for 30 minutes. B) Endoplasm / whole cell ratios show a reduction in endoplasmic spreading 
upon blebbistatin treatment.  C) As in A, cell were then fixed and stained for phalloidin and paxillin, all 




Endoplasm/whole-cell area ratios in blebbistatin-treated cells were lower than controls 
(Figure 25B).  In accordance with the endoplasmic spreading deficiency observed in Fln-
depleted MEFs, cells expressing GFP Vim 1-138, and WFA-treated cells, this deficiency 
was coupled with a defect in adhesion maturation (Figure 25C).  Thus, inhibiting myosin 
II blocked endoplasmic spreading, indicating that force generation, in addition to 
interaction of vIFs with FAs, was necessary for endoplasmic spreading. 
3.8	  –	  Summary	  and	  discussion	  
 
My earlier studies focused on the role of Flns in cell spreading and indicated that 
depletion of Fln levels caused an endoplasmic spreading defect (Lynch, et al., 2011).  
However, the spreading could depend upon the linkage between vIFs and mature 
adhesions and may have an indirect dependence upon Fln depletion. Indeed, either ALLN 
or NC-talin rescues endoplasmic spreading in a Fln depleted background (Figure 20E, 
Figure 21B).  Thus, Fln levels do not seem to be the only determinative factor in 
endoplasmic spreading, but large, mature adhesions are critical.  Further, we show that 
vIFs are linked to FAs in endoplasmic spreading and disruption of vIFs or the linkage 
leaves the endoplasm unspread.  Thus, we suggest that both mature adhesions and vIF 
connections are needed for endoplasmic spreading. 
In a model suggested recently (Xu, et al., 2010), mature adhesions can only form 
when there is competition between talin and Fln for calpain-mediated proteolysis.  When 
Fln levels are depleted, calpain-mediated proteolysis quickly turns over talin at the 
adhesion, precluding further maturation.  Adding FL FlnA back to the Fln depleted 
system restores talin-Fln competition for calpain proteolysis, thereby spreading calpain 
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cleavage between both talin and Fln and allowing adhesion maturation to occur.  
Inhibiting calpain cleavage in Fln-depleted cells allows further maturation to occur since 
talin now has a longer half-life at the adhesion.  Overexpressing NC talin achieves the 
same result, but bypasses the calpain cleavage step.  
Interestingly, FL talin expression does not rescue the Fln-depleted endoplasmic 
spreading defect (Figure 21B).  Under the model from Xu et al., adding to the pool of 
calpain cleavable molecules should decrease adhesion turnover and, according to our 
results, rescue endoplasmic spreading.  This is not the case however, potentially 
reflecting a cellular preference for Fln to be at the adhesion to allow further maturation.  
In this scenario, ALLN treatment of Fln-depleted cells or overexpression of NC talin 
would make the ~15% remaining cellular FlnA (Figure 12A) sufficient to allow adequate 
adhesion maturation to occur.  This is a subject for further inquiry.  Overall, our results 
indicate that mature adhesions are required for endoplasmic spreading.  
VIFs promote adhesion maturation and stabilization (Tsuruta, 2003), but the role 
of this phenomenon in the context of endoplasmic spreading has not been explored. The 
effects of vIF disruption have been reported in a number of systems, with a lack of 
polarization and raised central cellular regions being typical results (Ivanova, Margolis, 
Vasiliev, & Gelfand, 1976) (Goldman, Khuon, Chou, Opal, & Steinert, 1996) (Eckert, 
1986).  Our results with GFP-Vim 1-138 quantify the latter effect (Figure 22C), since 
reduced endoplasmic spreading necessarily results in a thicker central cellular region.  I 
also show GFP-Vim 1-138-transfected cells to be similar to Fln-depleted cells and Fln-
depleted cells transfected with FL Talin in that adhesion maturation correlates with an 
endoplasmic spreading defect (Figure 22D).  Similar to the Fln depleted system, a lack of 
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vIFs, immature adhesions, or both could cause the GFP-Vim 1-138-associated 
endoplasmic spreading defect.  ALLN treatment once again shed light on this issue: 
adhesions matured without vIF formation (Figure 22B) and, contrary to the Fln depleted 
case, endoplasmic spreading was not rescued (Figure 22C).  Therefore, neither vIFs nor 
mature adhesions are sufficient for endoplasmic spreading on their own.  This result is in 
agreement with that observed in the Fln depleted system: vIFs are present but proper 
adhesion maturation does not occur, perhaps because of the loss of the vIF-FA linkage.  
Hence, endoplasmic spreading does not occur. 
The necessity for both vIFs and mature FAs in the endoplasmic spreading 
mechanism leads to the logical conclusion that they most likely interact in some way 
during the process.  This interaction has been shown in other systems (Bershadsky & Tint, 
1987), but has never been approached in the context of endoplasmic spreading.  The 
GFP-Vim 1-138 system was unsuitable to probe this issue, as vIFs do not polymerize in 
the presence of this variant.  WFA treatment provided an alternative since WFA inhibited 
endoplasmic spreading (Figure 23C) and adhesion maturation (Figure 23E), yet still 
allowed vIF formation (Figure 23A).  In this system, as in Fln depleted cells, vIFs were 
not co-localized with or directed toward adhesive structures (Figure 23E), indicating that 
the vIF-FA interaction is required for endoplasmic spreading.  One caveat to using WFA, 
as with other chemical treatments, is that though it’s primary mechanism of action is 
known (covalent modification of vimentin monomers), it is unclear if it has any off-target 
effects, particularly on focal adhesion maturation. We postulate that adhesions do not 
mature in WFA-treated cells because of a lack of interaction with vIFs, however WFA 
may affect this process as well.  An important control to be explored in the future would 
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be to determine if WFA-treated cells have the ability to mature adhesions.  This could be 
accomplished through dual treatment of wild-type cells with WFA and ALLN.  If ALLN 
rescued adhesion maturation, then the effects of WFA would be limited in our system to 
inhibiting vIF extension to the periphery. 
Recent work (Burgstaller, Gregor, Winter, & Wiche, 2010) suggests that vimentin 
filament fragments must be transported along MTs and aggregate at adhesions before 
they form vIFs.  This aggregation is due to the presence of the plectin isoform P1f.  
Plectins are members of the plakin family of proteins that bind to each cytoskeletal 
system (MTs, IFs, and MFs) as well as to integrins (Jefferson, Leung, & Liem, 2004).  
VIFs overextend past peripheral adhesions in Fln depleted cells, suggesting that Fln 
depletion disrupts vIF fragment aggregation at adhesive sites.  Interestingly, I did not 
observe P1f in any of our wild type or experimental systems (data not shown).  This may 
be a result of disparities in the timing of experiments as I performed mine at 30 minutes 
after the initiation of spreading while Burgstaller et al. completed theirs at much later 
time points (~16 hours after spreading).  Early time points may require a different protein 
that, like P1f, associates with mature adhesions and vimentin, thereby promoting vIF co-
localization at adhesions. Zyxin is one such candidate (Lee, Mruk, Conway, & Cheng, 
2004), however I detected no differences in zyxin localization between Fln-depleted cells 
and their controls (data not shown).  Another protein that associates with both adhesions 
and vimentin is Fln (Kim, Nakamura, Lee, Shifrin, Arora, & McCulloch, 2010).  ALLN- 
and NC talin-mediated rescue of endoplasmic spreading in Fln depleted cells seemingly 
show that Fln is dispensable for endoplasmic spreading and adhesion maturation.  
However, Fln depleted cells still express ~15% of cellular FlnA levels (not to mention 
  
61 
relatively small quantities of FlnC).  Either ALLN treatment or NC Talin expression in 
Fln depleted cells could promote adhesion maturation adequately enough so that vIFs 
could aggregate at mature adhesions with low levels of Fln mediating the interaction.  
Future studies will focus on this intriguing possibility. 
Because vIFs must interact with mature adhesions to allow endoplasmic spreading, 
we postulated that contraction was necessary to perform the actual spreading of the 
endoplasm.  Indeed, I found this to be the case as blebbistatin treatment blocked 
endoplasmic spreading and adhesion maturation (Figure 25).  Collectively, my results 
suggest a robust mechanism for endoplasmic spreading (Figure 26).  The essential 
interaction of vIFs with mature adhesions connects contractile elements surrounding the 
endoplasm to the substrate, thus allowing force generation and subsequent spreading of 
the endoplasm.  As presented previously (Burgstaller, Gregor, Winter, & Wiche, 2010) 
(Lynch, et al., 2011), a cage-like structure of actin interspersed with IFs surrounds the 
endoplasm.  MTs typically extend toward the periphery as MT motors transport vimentin 
fragments outward.  As adhesions begin to mature, a vimentin-binding protein associated 
with mature adhesions causes the aggregation of vIFs at adhesions and subsequent 




Figure 26 - Endoplasmic spreading is a continuous process dependent on interaction between vimentin 






Once vIFs interact with the central cage, any contraction of elements comprising the cage 
or in connected stress fibers should result in endoplasmic spreading as long as a strong, 
stable connection exists between the cage and the substrate.   
Our previous work suggested two different phases of endoplasmic spreading, an 
initial flattening phase followed by a later contractile phase (Lynch, et al., 2011).  I 
proposed that once the cell was flat, forces exerted by polymerizing actin on the cell 
A cage-like structure surrounds the endoplasm from the beginning of spreading.  As microtubules migrate 
outward, vimentin fragments are transported out to maturing adhesions.  Vimentin fragments collect at 
maturing adhesions, subsequently forming vimentin filaments that can interact with the central endoplasmic 
cage.  Myosin II contraction in stress fibers and the endoplasmic cage causes the endoplasm to pull forward 
on the connection to the maturing adhesion, resulting in further maturation.  Vimentin filaments collect at 
the next round of adhesions, connecting with the spreading endoplasmic cage and allowing endoplasmic 




membrane of the leading edge would no longer be able to flatten the endoplasm further, 
necessitating a different mechanism.  Our current results lead to a contractile 
endoplasmic spreading model that plays a role throughout cell spreading, even allowing 
the coherent spreading of the endoplasm once the cell flattens.  After the steps outlined 
above, the continuous extension of MTs into the periphery promotes a new round of 
vimentin aggregation at more peripheral, “younger” adhesions.   These adhesions would 
then connect with the now more expansive central cage.  Contractile forces would pull on 
the substrate and spread the endoplasm further.  Interestingly, this model may also 
provide an explanation for the plateauing of endoplasm spreading at ~60-70% of cell area 
because the endoplasm would only spread into regions exhibiting mature adhesions and 
vIFs. 
In summary, our work provides a deeper understanding of the players involved in 
endoplasmic spreading that has, thus far, been elusive.  Numerous studies documented 
various aspects of the process but until now, their relation to endoplasmic spreading has 
not been fully realized.  Important questions linger however, including how vIFs interact 
with mature adhesions at early stages of spreading as well as temporal aspects of the 
process.  These will be assessed in future studies, potentially providing a more global 




Chapter	  4	  –	  Future	  perspectives	  
 
4.1	  –	  Further	  investigations	  of	  FlnA	  function	  in	  endoplasmic	  spreading	  
 
This thesis provides a framework for further studies into Fln’s role in cell motility 
as well as potential applications of the endoplasmic spreading mechanism.  Indeed, a 
number of important questions arise from the results of my research.  For instance, it is 
critical to continue characterizing the endoplasmic spreading mechanism and 
endoplasmic spreading defects.  An important point is that for all the mechanistic details I 
elucidated in this work, it remains unclear what is at the heart of an endoplasmic 
spreading defect; is it a disconnect in coherent force transmission between vIFs, the actin 
cytoskeleton, and mature focal adhesions?  If so, what binding partners mediate the 
vIF/mature focal adhesion interaction that is required for endoplasmic spreading? 
 Flns may be these critical mediators.  Of course, it is possible that their depletion 
simply leads to a lack of adhesion maturation and that this is the source of the Fln-
depleted endoplasmic spreading defect.  As already discussed briefly, FlnA binds 
vimentin and interacts with mature adhesions.  To further understand if FlnA is essential 
for endoplasmic spreading, I transfected Fln-depleted MEFs with GFP-tagged FlnA 
fragments comprising either FlnA domains 1-8, 8-15, 16-23, or 16-24.  Since vimentin 
binds FlnA along domains 1-8 and cryptic integrin-binding sites are located along the 
entire length of the FlnA molecule (Ithychanda, et al., 2009), I hypothesized that FlnA 
domains 1-8 would rescue the Fln-depleted endoplasmic spreading defect while the other 
FlnA fragments would not.  Unfortunately, I found no variation in the effects of any 
fragments on endoplasmic spreading, i.e. none of them rescued the endoplasmic 
spreading deficiency (Figure 27).   
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There are a number of possible explanations for this result.  For one, it is possible 
that cryptic integrin-binding sites on FlnA domains 1-8 are not uncovered in the absence 
of the rest of the molecule.  Since FlnA is a mechanosensitive protein (see section 4.2), 
this is a definite possibility.   
 
 
Figure 27 – FlnA fragments do not rescue the Fln-depleted endoplasmic spreading defect. 
 
 
The fragment would be able to bind vimentin, but not integrins, so forces generated 
within the endoplasm would still not be transmitted to the surface and the endoplasm 
would not spread.  Another possibility is that the N-terminal actin-binding domain of 
FlnA is required for endoplasmic spreading.  Of course, FlnA simply may not be the 
missing link between vIFs and mature adhesions.  Yet another possibility is that 



































Fln-depleted MEFs were transfected with the indicated GFP-tagged FlnA fragments.  None of the FlnA 




component, but from another process that takes over in the absence of FlnA or vIFs.  In 
any case, this is an important subject for further inquiry. 
 
4.2	  –	  Mechanosensitive	  functions	  of	  FlnA	  (Lynch	  &	  Sheetz,	  2011)	  
 
Regardless of its potential role in endoplasmic spreading, FlnA is an incredibly 
important cellular protein with diverse functions.  For example, FlnA is mechanosensitive 
(Yamazaki, Furuike, & Ito, 2002) (Pentikainen & Ylanne, 2009) (Lad, et al., 2007) 
(Kolahi & Mofrad, 2008) (Johnson, Tang, Carag, Speicher, & Discher, 2007) (Heikkinen, 
et al., 2009) (Furuike, Ito, & Yamazaki, 2001) and plays a role in mechanotransduction.  
Cellular mechanotransduction is the process by which cells detect external and internal 
mechanical signals and convert them to chemical responses.  In the context of cell 
adhesion to a substrate, externally applied forces produce similar effects as internally 
generated forces (Riveline, et al., 2001).  Focal adhesions grow and mature, while motile 
velocity decreases (Calderwood, et al., 2001).  How does the cell coordinate these 
responses at the molecular level?  Ehrlicher et al. suggested that mechanical strain in a 
FlnA-actin network would alter important interactions between the network and the cell.  
To test their hypothesis, they used a novel fluorescence microscopy-based method for 
measuring protein binding kinetics (Ehrlicher, Nakamura, Hartwig, Weitz, & Stossel, 
2011).  Two critical aspects of cellular mechanics were addressed by their study, 
cytoskeletal network linkage to the extracellular matrix and the dynamics of actin in the 
cytoskeleton.  Both were found to be responsive to strain on FlnA.   
As pointed out earlier, FlnA is a large, rod-like protein comprised of an N-
terminal actin-binding domain and 24 IgG-like domains that can bind numerous proteins.  
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The first 15 IgG-like domains are referred to as rod 1.  These domains interact end-to-end 
to produce an elongated structure that binds actin filaments along its length. Domains 16-
23 make up rod 2 (Nakamura, Osborn, Hartemink, Hartwig, & Stossel, 2007), a more 
compact region where domains interact in complex ways that result in cryptic binding 
sites only exposed when the molecule is under tension (Pentikainen & Ylanne, 2009).  
The C-terminal IgG-like domain allows the protein to homodimerize.  Each subunit of a 
FlnA dimer is capable of binding lengthwise along an actin filament via interactions with 
rod 1, thereby orthogonally crosslinking two actin filaments and creating a network of 
actin filaments.  Although a Fln-crosslinked network is capable of transmitting forces 
over long distances (Wang, Tytell, & Ingber, 2009); cohesive propagation of forces in 
cells between adhesions depends upon myosin contractility (Cai, et al., 2010) (Rossier, et 
al., 2010).  In cells, the loss of Flns results in the loss of normal focal adhesions and 
reduced linkage between cytoskeletal compartments (Baldassarre, Razinia, Burande, 
Lamsoul, Lutz, & Calderwood, 2009) (Lynch, et al., 2011).   However, the Fln network 
can have other roles than just crosslinking.  As a mechanotransducer, strain generated 
within this network (internally or externally) can strain the FlnA dimer at its crosslinks. 
One way to explain the effects of FlnA on many cell activities is that strain of FlnA could 
alter its binding affinity for other components as has been shown for cell cytoskeletons in 
general (Sawada & Sheetz, 2002). 
Ehrlicher et al. tested this hypothesis using a novel technique known as 
fluorescence loss after photoconversion, or FLAC.  Conceptually similar to fluorescence 
recovery after photobleaching (Sprague, Pego, & Stavreva, 2004), a given protein’s 
binding partner is tagged with a photoactivatable fluorophore that does not fluoresce until 
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excited by a pulse of high energy light.  Once fluorescent, unbound proteins rapidly 
diffuse away from the site of excitation while proteins bound to the actin-FlnA network 
must first release.  The result is typically a two-component exponential decay in 
fluorescence intensity (a very rapid, unbound and slow, bound component). Although a 
high density of FlnA can result in rebinding and multiple release steps, small activation 
volumes and excess binding protein reduce the possibility. Thus, the slow decay 
component can be a measure of the off-rate constant for the bound complex.  Assuming 
that the on-binding rate is unchanged, changes in off-rate constant would reflect changes 
in the equilibrium binding constant, i.e. the fraction bound.  
         Ehrlicher et al. then used an in vitro FLAC assay to test how strain in a FlnA-
actin network would alter binding.  The experimental apparatus consisted of a stationary 
cover glass on the bottom, a reconstituted FlnA-actin network in the middle that also 
contained a specific FlnA binding partner, and a piezo-driven upper plate capable of 








A) Schematic depicting the effect of unidirectional strain applied to an actin-FlnA network.  B) Cartoon of 
fluorescence loss after photoconversion (FLAC) data for each FlnaA binding partner tested.  After 
photoactivation (PA) on an unstressed network, FilGAP has a longer lifetime than integrin at FlnA 
crosslinks.  After PA in a stressed network, the opposite result is observed.  C) Model of FlnA crosslinks 





The FlnA binding partners were either a peptide representing the FlnA binding site from 
integrin β7, which binds at cryptic binding sites on FlnA, or FilGAP, a GTPase that 
specifically inactivates Rac and binds to domain 23 of FlnA, near its C-terminal 
dimerization domain.  Rac inactivation is typically associated with a shift toward slower 
actin dynamics and adhesion maturation.  Thus, alterations in binding of integrin β7 tail 
peptide and FilGAP have implications for cytoskeleton-matrix interactions and actin 
dynamics, respectively.  Finally, to determine if cellular motors could produce similar 
strains, non-muscle myosin II was incubated with the network until all ATP was 
hydrolyzed.  After the network had time to relax, strain was induced by uncaging 
photolabile ATP, causing further myosin contraction. 
The reported results were striking: applying an external strain caused stronger 
binding of the integrin peptide to FlnA while weakening FilGAP binding. Further, 
FLAC-based binding kinetics of photoactivatable FlnA showed a turnover time on the 
order of six minutes.  This observation provided an internal control, as any strain exerted 
on the system would be relaxed over time due to the dynamic nature of FlnA crosslinking.  
Accordingly, FLAC measurements taken after relaxation of the actin network showed 
increased FilGAP binding. When the relaxed network contained myosin, contraction 
induced by ATP uncaging produced internal strain.  FLAC measurements of networks 
undergoing internal strain showed that integrin binding strength increased while FilGAP 
binding became weaker (Figure 28B).  It is interesting to note that the off-rate of FilGAP 
was decreased in the presence of myosin and contraction did not cause a decrease to the 
same level as the externally applied strain.  However, molecular mechanotransduction 
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through FlnA generally behaves in a similar manner regardless of whether strain is 
exerted externally or internally.  
How could applied strain elicit stronger binding of one binding partner but 
weaken the binding of another?  There are two major effects of the strain: one would be 
to alter the angle between the FlnA rods and the other would be to cause domain 
unfolding as suggested by the fact that the integrin binding site is cryptic.  In the first case, 
the FilGAP binding domain, domain 23, is close enough to the dimerization domain, 
domain 24, such that lower crosslinking angles could allow FilGAP to simultaneously 
interact with both subunits of the homodimer.  Increasing the crosslinking angle would 
increase the distance between each subunit’s FilGAP-binding domain, potentially 
weakening the binding strength of FilGAP to FlnA.  Alternatively, the applied tension in 
the network could mechanically stretch FlnA (in vitro measurements of unfolding show 
that it occurs in a physiological force range (Chen, Zhu, Cong, Sheetz, Nakamura, & Yan, 
2011)) exposing its cryptic integrin-binding sites and promoting the integrin-FlnA 
interaction (Figure 28C). 
The findings of Ehrlicher et al. provide insights into the complex issues of how 
matrix-cytoskeleton binding and actin dynamics are regulated by mechanical forces. 
They also support previous observations related to FlnA.  For one, Ithychanda and Qin 
recently demonstrated that FlnA has the potential to bind integrin at numerous cryptic 
sites along its length (Ithychanda, et al., 2009).  The authors proposed, as have others, 
that FlnA mediates adhesion maturation by clustering integrins into larger adhesive 
structures.  Recent work from our lab and others shows that cells depleted of Flns cannot 
generate stable levels of internal force (although peak forces are at control levels) and as 
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a result, adhesions do not mature (Lynch, et al., 2011), which is in agreement with the 
finding that internal strain increases integrin binding in FlnA crosslinked actin networks.  
Furthermore, because local application of forces causes inhibition of cell membrane-
proximal Rac in a FilGAP-dependent manner (Shifrin, Arora, Ohta, Calderwood, & 
McCulloch, 2009), the result that FilGAP binding is weakened by application of stress on 
the network also fits well with cell-based studies.  Ehrlicher et al. also suggest that 
regulation of FilGAP could be purely mechanical in nature, as FilGAP would be tightly 
bound to FlnA until force generation occurs, at which point the crosslinking angle of 
FlnA would increase, thereby weakening FilGAP binding and promoting its recruitment 
to the leading edge of the cell.  An alternative explanation is that FlnA stretching results 
in conformational changes that weaken FilGAP binding without a crosslinking angle 
change.  In any case, these results are important, for many cell activities require that the 
responses to mechanical strain be robust and include stabilization of matrix-cytoskeleton 
linkages and alterations of actin dynamics. 
 FlnA is now added to the list of intracellular proteins that respond to strain by 
altering either binding (talin), enzymatic (titin), or substrate (p130Cas) functions (Moore, 
Roca-Cusachs, & Sheetz, 2010).  The biochemical complexity of focal adhesions, which 
can contain over 100 types of molecules (Zaidel-Bar, Itzkovitz, Ma'ayan, Iyengar, & 
Geiger, 2007) that are potentially mechanosensitive in their binding (Schiller, Friedel, 
Boulegue, & Fassler, 2011) can be at times discouraging, and mechanotransduction is 
often thought of as a tangled web of biochemical signaling. Ehrlicher et al., however, 
have shown us that strain in the actin-FlnA network can simultaneously regulate both 
actin dynamics and adhesion of the actin cytoskeleton to the surrounding matrix.  Further 
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studies, however, are required to elucidate how much stretching of FlnA occurs during 
cell mechanotransduction and where its activities fit into microenvironmental controls of 
cell stasis versus growth or differentiation. 
 
4.3	  –	  Stretching	  of	  filamin	  A	  in	  live	  cells	  
 
To explore the extent of FlnA stretching in cells, I generated FlnA constructs 
expressing an N-terminal GFP and a C-terminal mCherry sequence (see Figure 29 for 
illustration of this concept using talin).  
 
Figure 29 – Schematic of GFP-talin-mCherry fusion protein (Margadant, et al., 2011) 
 
These constructs were expressed in wild-type fibroblasts that were plated on fibronectin-
coated glass and visualized in two-color TIRF with high temporal resolution.  To prevent 
photobleaching artifacts, total acquisition time was restricted to two minutes with a time 
interval of two seconds between frames.  An algorithm described previously was used to 
analyze the resulting image sequences (Margadant, et al., 2011).  At a basic level, the 
algorithm detects signals in one channel that co-exist with signals from the other channel 
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within a given radius (Figure 30).  
 
Figure 30 – Schematic showing basic concepts of detecting protein stretching (Margadant, et al., 2011) 
Dimers can also be accounted for in various ways (e.g. for FlnA, two N-terminal signals 
must be associated with a single C-terminal signal to be detected).  After filtering signal 
sets based on signal quality and intensity, the algorithm calculates the displacement 
between the signal centroids over time, yielding a temporal measure of FlnA stretching 
length in living cells. 
 Preliminary results are promising: FlnA appears to be stretched to lengths of 
about 100-150 nm.  FlnA has an unstretched length of approximately 80 nm, so the 
measured stretched lengths are reasonable.  Blebbistatin and Y-27632 (a Rho kinase 
inhibitor) both appear to decrease FlnA stretching length, suggesting that stretching is 
subject to mechanical forces.  Additionally, comparing results from GFP-talin-mCherry 
and GFP-FAK-mCherry constructs shows a disparity in stretched length between each of 
these proteins as well as FlnA.  In short, I have begun monitoring FlnA stretching in live 
cells.  Data analysis is ongoing, but should lead to important discoveries for a number of 
processes related to motility, especially integrin-binding.   
 




As important and satisfying as basic research can be, a researcher should always 
consider potential application to real world problems.  Biomedical research has revealed 
a number of organ-specific cancer biomarkers, molecules that, when detected, suggest 
that a certain tissue may be at risk.  Downstream of initial tests, cells and tissues are 
assayed in a number of ways to determine the likelihood of cancerous transformation.  
New determinative factors, based on the general properties that all solid cancers must 
have, would be informative and complementary to any diagnosis.  On the most basic 
level, metastatic solid cancers must have the ability to divide uncontrollably and become 
motile to other parts of the body.   
My thesis work began with a focus on the cell spreading phenotypes associated 
with various cancer cell types.  The experiments were part of a larger study in which we 
determined that secondary tumor cells had a preference for substrates of certain rigidities 
that correlated with where the cells metastasized (Kostic, Lynch, & Sheetz, 2009).  For 
our study, we used cancer cells of disparate metastatic potential and tissue tropism.  
Tissue tropism refers to the preference of a tumor cell to metastasize to a certain tissue 
over other tissue types.   
In brief, human breast cancer cells were inoculated into mouse ventricles, where 
they eventually metastasized to form bone lesions in the leg.  Cells from the lesions were 
then isolated, expanded, and re-inoculated into mice.  Cancer cells were subsequently 
collected from any resultant lesions.  Certain lines formed lesions in bone tissue, while 
others preferred the lung (Kang, et al., 2003) (Minn, et al., 2005) (Minn, et al., 2005).  As 
such, when we assessed their rigidity sensing capabilities, cells that metastasized to hard 
regions (bone) preferred spreading on rigid substrates while those that metastasized to 
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soft regions (lung) preferred spreading on soft substrates.  These results indicated that the 
rigidity sensing response in breast cancer cell lines correlated with the tissue tropism. 
 I contributed to this work by determining if cells of varying metastatic potential 
displayed differences in cell spreading.  Breast cancer lines (cancerous and non-
cancerous) were allowed to spread on fibronectin-coated glass for 30 minutes while being 
recorded by time-lapse differential interference contrast microscopy.  I found no 
significant correlation between spreading rates and metastatic potential, so I did not 
pursue the experiments further.   
However, after making endoplasmic spreading and its mechanisms the focus of 
my thesis, revisiting the breast cancer cell motility data revealed a potential defect in 
endoplasmic spreading amongst cancer cells that was not observed in controls.  In 
particular, scp2, which is metastatic to bone, appeared to have the most severe 
endoplasmic spreading defect, while scp3, which is metastatic to lung, may carry a lesser 
defect.  Scp21, which is non-metastatic, and MCF10A, the control cells, appeared to 
spread the endoplasm normally.  These preliminary results indicate that an endoplasmic 
spreading defect may be a hallmark of metastatic breast cancers, particularly those that 
metastasize to rigid regions of the body (Figure 31).  That said, endoplasmic spreading is 
most likely not directly linked to metastasis.  Other phenotypes observed in parallel with 
defective endoplasmic spreading, such as decreased stress fibers and impaired adhesion 
maturation, may promote metastasis in vivo.  Decreased stress fibers could make a cell 
more motile, since stress fibers are typically associated with strong adhesion to a surface.  
Impaired adhesion maturation could likewise make cells more motile since mature 










At this point, though we can speculate, it is unclear why endoplasmic spreading 
defects might be associated with metastatic breast cancer cells.  Also, an endoplasmic 
spreading defect has not been quantitatively confirmed in metastatic breast cancer cells, 
only qualitatively observed.  Despite this, loss of FlnA causes cells to become metastatic 
(Xu, et al., 2010), so I suggest that some or all of the phenotypes observed in Fln-
depleted MEFs that lead to an endoplasmic spreading deficiency may also be present in 
metastatic cancer cells in general.  This is a topic for future studies. 
(A-D) Breast epithelial cell line MCF10A (A), and breast cancer cell lines SCP 2 (B), SCP 3 (C), and SCP 
21 (D) were plated on FN-coated glass and their spreading was recorded. SCP 2 was most metastatic to the 
bone, SCP 3 to the lung, whereas SCP21 was not metastatic.  The time course of representative cells is 
shown. No significant changes in cell area or motility were observed in cells that were observed longer than 
20 min (up to 2 h). However, SCP2 appeared to carry an endoplasmic spreading deficiency.  SCP 3 and 
SCP 21 appeared to spread the endoplasm normally. 
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In summary, this thesis provides a framework for future research on the 
endoplasm, both basic and applied.  Endoplasmic spreading has been largely ignored for 
many years and it is my hope that this thesis at least underlines the integral role of the 






First	  manuscript	  materials	  and	  methods	  
 
Antibodies and membrane dyes: Fixable FM1-43x membrane dye and FM4-64 
membrane dye were purchased from Molecular Probes.  Rabbit polyclonal anti-FlnA, 
mouse monoclonal anti-paxillin, mouse anti-β-tubulin, mouse anti-GAPDH, and 
rhodamine-phalloidin were purchased from Novus Biologicals, BD Biosciences, Seven 
Hills Bioreagents, Santa Cruz Biotechnology, and Molecular Probes, respectively.   
 
Cell culture: FlnA +/+, FlnA -/-, FlnB +/+, FlnB -/-, and Fln-depleted MEFs were 
maintained in high glucose DMEM (Gibco) + 10% FBS (Gibco) at 37°C.   
 
Constructs and transfection: pSilencer H1-3.1 puro expression vector (Ambion) was used 
as described previously (Cai et al., 2006) but targeting Mus musculus flnA with the 
sequence: 5’-CCATACTTACTGTATCCGA-3’.  Insert design was conducted using the 
pSilencer insert design tool on the Ambion website.  For transfection detection, this 
vector was engineered to express GFP as well.  pSilencer H1-3.1 puro-GFP bearing a 
non-targeting sequence was used as a control.  pLNCX-paxillin-RFP was from Dr. 
Michael Partridge (Columbia University).  pEGFP-3xEMTB was from Dr. Chloe 
Bulinski (Columbia University).  pEGFP-FlnA-full and calpain-uncleavable FlnA-GFP 
was from Dr. Donald Ingber (Children’s Hospital and Harvard Medical School).    FlnA 
Δ19-21-GFP was from Dr. David Calderwood (Yale University).  RFP-EB3 was from Dr. 
Richard Vallee (Columbia University).  pRFP-ER was from Clontech.  Transfection was 
accomplished using the Nucleofector system (Amaxa) or FuGENE HD transfection 
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reagent (Roche).  FlnB -/- MEFs were transfected according to manufacturer’s protocol, 
incubated for 1 day, exposed to 1.75 µg/ml puromycin (Sigma) in DMEM for 3 days, and 
used for experimentation. 
 
FACS and Western blotting: Cells were transfected, allowed to recover for 1 day, 
exposed to 1.75 µg/ml puromycin in DMEM for 3 days, trypsinized, and resuspended in 
serum-free DMEM.  Samples were sorted by a FACSAria cell sorter (BD Biosciences), 
centrifuged, and lysed with RIPA buffer.  After sonication, samples were stored at -80°C.  
SDS-PAGE and Western blotting was then performed as described previously (Zhang et 
al., 2008). 
 
Cover glass treatment and spreading assay preparation: On the day of the experiment, 
silanized cover glasses were treated with a droplet of 10 µg/ml human plasma fibronectin 
(FN) (Roche) and incubated at 37°C for 1 hour.  Meanwhile, cells were trypsinized and 
resuspended in serum-free DMEM (w/o phenol red) (Gibco) for 30 minutes (for 
nocodazole studies, nocodazole was diluted in serum-free DMEM at 10 µM).  Cells were 
then loaded into a sealed live-cell imaging chamber with a FN-coated cover glass on the 
bottom and an uncoated cover glass on top and spread at 37°C.  DIC and epifluorescence 
microscopy was performed on an Olympus IX70 microscope mounted with a UPlanApo 
20x, 0.70 NA objective (Olympus) and a Roper Scientific CoolSnap FX cooled CCD 
camera (Photometrics) while TIRF microscopy was performed on an Olympus IX81 
microscope with a PlanApo 60x, 1.45 NA oil immersion TIRFM objective (Olympus) 




Correlative cell spreading assay with immunostaining: Cells were prepared as described 
above but loaded into a modified imaging chamber consisting of a FN-coated cover glass 
on the bottom, a circular rubber gasket in the middle, and an uncoated cover glass on top.  
Cells were then verified for GFP expression by epifluorescence microscopy and imaged 
with DIC microscopy for 45 minutes.  Coated cover glass was then removed from the 
microscope, fixed and stained as described above, and imaged once again to verify FlnA 
knockdown. 
 
Immunostaining and FM-143x / FM4-64 staining: Cells were fixed with 3.7% 
formaldehyde in PBS, quenched with 50 mM ammonium chloride in PBS, and 
permeabilized with 0.1% Triton X-100 in PBS.  Primary and secondary antibody 
stainings were performed at 37°C for 1.5 hours each.  Confocal imaging was completed 
on an Olympus IX81 microscope with a PlanApo 60X, 1.40 NA oil immersion objective 
and FluoView imaging software (Olympus).  FM1-43x / FM4-64 staining was 
accomplished by briefly fixing cells with 7.4% (2X) formaldehyde followed by a 5 
minute incubation with FM1-43x / FM4-64 in 1X formaldehyde / PBS.   
 
Quantification of distance between MT boundary and cell edge: Fln-depleted cells and 
their controls were transfected with 3x-ensconsin-GFP and allowed to spread.  Distances 
between the MT boundary and cell edge were determined by drawing lines perpendicular 
to the cell edge from the edge to the MT boundary.  At least ten measurements were 




Measurement of MT growth rates:  EB3 signal was tracked using Nano Tracking plug-in 
for ImageJ (Nicolas Biais, Columbia University, referenced in (Cai et al., 2006; Biais et 
al., 2008)).  Displacement plots showed regions of growth, pause, and catastrophe.  
Regions of highest growth were analyzed for each cell type/condition in Matlab. 
 
Preparation of FN-coated PDMS pillars and force generation assays: PDMS was prepared 
in a 10:1 ratio of PDMS/curing agent, placed in a vacuum chamber to remove bubbles, 
and molded over silicon wafers for 14 hours at 65°C.  Pillars were peeled in ethanol and 
quickly transferred to PBS.  Pillars were then incubated at 37°C in 10 µg/ml FN for 1.5 
hours for coating.  After rinsing with PBS, cells were plated with CO2-independent media 
and imaged on coated pillars for ~ 30 minutes on an Olympus IX70 microscope mounted 
with a LUCPlanFl 40x, 0.60 NA objective (Olympus). 
 
Image analysis and statistics: Analysis of Western blots was accomplished using the 
“Integrated Density” measurement in ImageJ (http://rsb.info.nih.gov/ij/).  Endoplasm and 
whole cell areas of DIC images were measured by hand using the “Area” measurement in 
ImageJ.  While in some cells the endoplasm-ectoplasm boundary is easily identifiable 
with a still DIC image, all of our measurements were performed on movies at the 
appropriate time point, making it easier to determine the endoplasm-ectoplasm boundary 
in DIC by tracking organelle movements.  Kymographs were generated in ImageJ with 
the Multiple Kymograph function (J. Rietdorf and A. Seitz, European Molecular Biology 
Laboratory, Heidelberg, Germany).  Analysis of force generation on PDMS pillars was 
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completed using Nano Tracking.  All other image processing was completed in ImageJ.  
All graphical data was completed in Excel 2008 (Microsoft) as was the execution of two-
tailed t-tests and calculation of standard deviations and standard errors.  Statistical 
analysis was done using SigmaStat (Systat) with two-tailed student’s t-test when two 
cases were compared and with analysis of variance (ANoVA) tests when more 
comparisons were done.  Line art was completed in Powerpoint 2008 (Microsoft). 
Second	  manuscript	  methods	  
 
Antibodies and Reagents: Mouse monoclonal anti-paxillin, mouse monoclonal anti-
vimentin, rhodamine-phalloidin and anti-zyxin were purchased from BD Biosciences, 
Abcam, Molecular Probes, and Abcam respectively. Anti-plectin P1f was obtained from 
Gerhard Wiche (University of Vienna, Austria) (Baldassarre et al., 2009; Burgstaller et 
al., 2010). N-[N-(N-Acetyl-L-leucyl)-L-leucyl]- L-norleucine (ALLN), withaferin A 
(WFA), blebbistatin, and nocodazole were all purchased from Sigma-Aldrich. 
 
Constructs and Transfection: pSilencer H1–3.1 puro expression vector (Ambion, Austin, 
TX) was used as described previously (Cai et al., 2006) but targeting Mus musculus flnA 
with the sequence: 5′-CCATACTTACTGTATCCGA-3′. Insert design was conducted 
using the pSilencer insert design tool on the Ambion Web site. For transfection detection, 
this vector was engineered to express mCherry in place of GFP. pRFP-ER was obtained 
from Clontech (Mountain View, CA). Full-length (FL) and Non-Cleavable (NC) Paxillin-
GFP, as well as FL/NC Talin-GFP, were obtained from Anna Huttenlocher (University of 
Wisconsin-Madison) (Cortesio et al., 2011; Franco et al., 2004). FL/NC FlnA-GFP was 
obtained from Donald Ingber (Children’s Hospital and Harvard Medical School, Boston, 
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MA) (Mammoto et al., 2007).  Full-length Vimentin-GFP and Vimentin 1-138 –GFP 
were obtained from Robert Goldman (Northwestern University) (Chang et al., 2009). 
Transfections were accomplished using the Nucleofector system (Lonza, Walkersville, 
MD).  FlnB–/– MEFs were transfected according to the manufacturer’s protocol, 
incubated for 1 day, exposed to puromycin at 1.75 μg/ml (Sigma, St. Louis, MO) in 
DMEM for 3 days, and used for experimentation. 
Cell Culture: FlnB-/- and RPTPα+/+ MEFs were maintained in high-glucose DMEM 
(Life Technologies, Carlsbad, CA) + 10% fetal bovine serum (Life Technologies) at 
37°C. 
Chemical Treatment: Fln-depleted and negative control MEFs as well as RPTPα+/+ 
MEFs transfected with Vim-GFP and Vim 1-138 –GFP were incubated in 50µM ALLN 
in DMSO in serum media (FBS+DMEM) for 22 hours prior to experimentation.  Fln-
depleted MEFs were incubated with 10µM Nocodazole (an equivalent volume of DMSO 
for control cells) in serum-free media for 30 minutes. RPTPα+/+ MEFs were incubated 
with 50µM Blebbistatin (an equivalent volume of DMSO for control cells) in serum-free 
media for 30 minutes. RPTPα+/+ MEFs were incubated with 500nM WFA (an 
equivalent volume of DMSO for control cells) in serum media for 22 hours. Cell 
spreading assays were then conducted, either with live-cell imaging or fixation and 
immunostaining. 
Cover glass treatment and spreading assay preparation: On the day of the experiment, 
silanized cover glasses were treated with a droplet of FN (Roche) at 10 μg/ml and were 
incubated at 37°C for 1 hour. Meanwhile, cells were trypsinized and resuspended in 
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serum-free DMEM (without phenol red) (Life Technologies) for 30 min prior to 
experimentation.  DIC and epifluorescence microscopy were performed on an Olympus 
IX70 microscope (Center Valley, PA) mounted with a PlanApo 60×, 1.40 NA objective 
(Olympus) and a Roper Scientific Cool-Snap FX cooled CCD camera (Photometrics, 
Tucson, AZ). Imaging software used was SimplePCI (Hamamatsu Corporation, 
Sewickley, PA). 
Immunostaining: Cells were fixed with 3.7% formaldehyde in phosphate-buffered saline 
(PBS), quenched with 50 mM ammonium chloride in PBS, and permeabilized with 0.1% 
Triton X-100 in PBS. Primary and secondary antibody stainings were performed at 37°C 
for 1.5 hours each. Confocal imaging was completed on either an Olympus IX81 
microscope with a UPlanApo 60×, 1.40 NA oil immersion objective and FluoView 
imaging software (Olympus), or a Zeiss LSM 700 microscope with a Zeiss Plan-
APOCHROMAT 63x 1,4 Oil DIC objective and Zeiss Zen Imaging Suite imaging 
software. For time-course assays, immunostaining was begun after 10, 20 and 30 minutes. 
Image Analysis and Statistics:  Endoplasm - whole cell area ratios were measured in the 
method previously reported (Lynch et al., 2011).  Focal adhesion areas were analyzed by 
hand using the “Area” measurement tool in ImageJ. Paxillin signals smaller than 0.5µm2 
were not considered. Between 10 and 15 representative FA areas per cell were quantified 
after thresholding.  Determination of vIF connection with FAs was quantified by 
summing the total adhesions per cell and assessing how many were contacted by vIFs.  
The ratio of those FAs that colocalized with a vimentin IF to the total number of FAs was 
then calculated.  Average distance between vIFs and the cell edge was assessed by 
measuring 10 regions around each cell for the distance from the tip of a vIF to the cell 
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edge (orthogonal to the cell edge).  All p-values were generated using the Student’s t-test 
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